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1. INTRODUCTION 
Respiratory tract infection refers to the infectious diseases in the respiratory tract. An 
infection of this type is normally further classified as an upper respiratory tract infection (URI 
or URTI) or a lower respiratory tract infection (LRI or LRTI). The upper respiratory tract is 
generally considered to be the airway above the glottis or vocal cords. However, this includes 
the nose, sinuses, pharynx, and larynx. The lower respiratory tract consists of the trachea 
(wind pipe), bronchial tubes, the bronchioles and the lungs. The upper respiratory tract 
infection (URI) is a nonspecific term used to describe acute infections involving the nose, 
paranasal sinuses, pharynx, larynx, trachea, and bronchi.Upper respiratory tract infection 
(URTI) has been recognized as one of the most common medical problems in the daily lives 
of people worldwide. In 2015, 17.2 billion cases of upper respiratory infections occurred. As 
of 2014, upper respiratory infections caused about 3,000 deaths down from 4,000 in 1990. 
 
A strong confirmation for the prevention of URTI is rather inadequate, and thus, the patients 
take preventive measures on the basis of their own experience or preferences. However, an 
URTI is referred to as a a viral infection causing inflammation and infection in the nose and 
throat. URTIs are contagious which remain for few hours to 2-3 days of exposure. Also, the 
symptoms have been knowm to last from 7-10 days, but reports have shown that the 
symptoms may last even longer. 
 
URTI has been regarded as a nonspecific term that is used to describe acute infections 
involving the nose, paranasal sinuses, pharynx, larynx, trachea, and bronchi. Although, there 
have been a range of related conditions that may have similar or overlapping clinical 
presentations within each category of illness, and hence, judgment is required in determining 
the affected respiratory mucosal part. Various signs and symptoms of URTIs have been 
reporets which include stuffy and runny nose, sneezing, coughing, sore throat, fever, 
vomiting, irritability, loss of appetite, and watery eyes. However, URTI infections have been 
suggested to be mild and self limiting, but they have been reported to lead to life threatening 
complications. Further, the causes of URTIs have been attributed to viral, but studies have 
also suggested the cause to be bacterial. Viruses causing most URTIs include rhinovirus, 
parainfluenza virus, coronavirus, adenovirus, respiratory syncytial virus, coxsackievirus, and 
influenza virus in most cases, whereas beta-hemolytic streptococci, Corynebacterium 
diphtheriae, Neisseria gonorrhoeae, Arcanobacterium haemolyticum, Chlamydia 
pneumoniae, Mycoplasma pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae, 
Bordetella pertussis, and Moraxella catarrhalis are the most common bacteria causing 
URTIs. 
 
Mostly the pediatric population is probably prone to this type of respiratory infections. Once 
they are infected they show all the symptoms one by one as said earlier. Since children more 
sensitive to the illness, it causes more pain in the throat region which causes difficulty in 
swallowing and breathing, in allopathic system. The children are treated with Anti-biotics, 
Anti-histamine and De-congesants. However, the results have not been satisfactory due to the 
development of resistance to antimicrobial drugs as with all medicines; there are a number of 
side-effects that have been reported with each of the different antibiotics. Common side-
effects include soft stools, Diarrhoea or mild stomach upset, Nausea and Peptic ulcer. Less 
commonly, some people have an allergic reaction to antibiotics. Antibiotics can kill off 
normal defense bacteria which live in the oral cavity and bowel. This may then allow thrush 
or other bad bacteria to grow. 
But in traditional system most of the formulations in siddha medicine is mostly made with 
herbs and herbo-mineral drugs for pediatric population in order to eliminate these major 
issues.  Hence I have selected the  a siddha formulation SIRUPULLADI ENNAI which has been 
mentioned in the sasthric Siddha literature  balavagadam having the indication to treat Kanam  
All ingredients of this experimental medicine are purely herbal. It is very cost effective, 
easily prepareble, easily palatable so it may be safe and will have efficacy in treating 
NEERKANAMANTHAM in children. The main ingredient of this formulation is Sirupulladi 
leaf which has Anti-bacterial activity and Anti-inflammatory activitiy. The other ingredients 
are Sanaki leaf, Poduthalai leaf, Avuri leaf, Kalarchi leaf, Gingili oil. 
 
This dissertation work aims to evaluate the pharmacological activity, physicochemical 
analysis and clinical studies of SIRUPULLADI ENNAI in an attempt to provide a direction for 
further research. 
 
 
 
 
 
 
 
 
 
 
  
 
 
AIM AND OBJECTIVES 
  
2. AIM AND OBJECTIVES 
Primary Aim and Objectives 
To evaluate the efficacy of SIRUPULLADI ENNAI for the management of 
NEERKANAMANTHAM in Children under the following preclinical and clinical 
parameters 
 Physico – chemical Analysis, Anti Inflammatory studies, Chemical analysis of trial 
drug  
 Clinical studies 
Secondary objectives 
 To collect and review the ideas mentioned in the ancient Siddha literature about the 
disease NEERKANAMANTHAM. 
 To explore Definition, Etiology, Clinical features, Diagnosis, Investigations and 
treatment of NEERKANAMANTHAM as laid down from various siddha literature. 
 To make the correlative study of the siddha and modern aspect of this diseases. 
 To use the modern parameters in the investigation of the disease that enhances to 
observe the progress of the patient.  
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3. REVIEW OF LITERATURE 
 3.1 SIDDHA ASPECT 
 “rPuzpe;judhu; ghjk; Njtpapd; jpUe;jhs; Nghw;wp 
    jhuzpklthupd;w jdae;jd; rpNyw;g Nuhfk; 
 ehuzpe; jpUgj;njhd;Wk; ew;Fzq;fl;l rhj;jpak; 
 ghu;jdpy; kUe;Jq; $l;b gy gy fpwpif nrhy;Nthk” ; 
,ay; :(Definition)  
 khjhf;fspd; gpjhf;fspd ehj tpe;Jf;fslq;fpa thjhjp Njh\q;fspdpd;W 
cw;gj;jpahfpf; fUg;ghraj;J rpRitg; gw;wp mr;rpRthdJ VOtif jhJf;fSk; 
td;ikailAq;fhyj;J mij Nehahy; tUe;j nra;Ak; Neha;. 
  A congenital disease of the child arising from the maturity of bad humours inherited 
from the parents. It is an atrophy resulting from the enlargement of the bowels. This disease 
progresses in several forms as the child advances in age. (T.V.Sambasivam Pillai part II) 
Foe;ijfSf;F fzr;#l;bdhYk; ghypd; Fw;wj;jpdhYk; tapW Nfhshwile;J 
clk;gpy; fdg;Gz;lhfpr; Ruk; tpau;it euk;G typ Kjypad Vw;gl;L vYk;G FWfp 
clk;G ,isj;J tUk; Neha;. 
 A constitutional disease in children arising from congenital heat or bed nutrition 
resulting in diarrhoea of the stomach and glowing head in the body.It is marked by fever 
sweating of the head, nervous affection of the bones, general emaciation.(T.V.Sambasivam 
Pillai).  
rpj;j kUj;Jt E}yhd ghythflk; (Foe;ij kUj;Jtk;);>fzj;jpid %d;W 
tifapy; tiuKiwg;gLj;Jfpd;wJ.mit tUk; topapidg; nghWj;J ,U gphpTfSk;> 
Njhd;Wk; tajpidg; nghWj;J xU gphpTk; MFk.;  
fzk; Njhd;Wk; taJ: 
―vz;zNt fz%d;W tUle; njhl;Nl 
Vohz;L kl;Lf;F kpUf;Fq; fhyk;‖ - ghythflk;. 
  taijg; nghWj;J %d;W fUj;Jfs;: 
 3-7tajpy; cz;lhjy; 
 ghYk; NrhWk; cz;Zk; gUtj;jpy; cz;lhjy; 
 3-12 tajpy; cz;lhjy; 
 Neha; tUk; top (Etiology) 
 “G+q;Foy; khNj Nfsha; 
Gjy;tUf;F Mz;L nrd;why; 
ePq;fUk; fizapd; Njh\k; 
 epiwe;jNjhu; euk;ngy;yhk; 
jhq;fpNa epd;W jhDk; 
rhUNk Cidg; gw;wp 
ahq;Fs nuj;j nky;yhk; 
mKjd; cz;Z nkd;Nw…‖ 
ghyUf;F Mz;L nrd;why; fizapd; Njhrk; vOfpwJ. ,j;Njhrk; euk;ngy;yhk; 
jq;fp epd;W Cid gw;Wk;. ,jdhy; uj;jk; tw;Wk;. 
―epiwe;j njhU Mz;bd; Nkyha; 
    gz;LNru; ghyu; nka;apy; 
  gd;dpnuz;lhz;L epw;Fk; 
 Fd;wpdpy; cikahs;f; fPrd; 
 Fwpj;jpij cij;jhnud;nw…‖ 
,g;gb te;j fizNjhrk;> vOe;J nghq;fp ghyfdpd; clk;gpy; 12 Mz;L epw;Fk;. 
Fd;wpd; kPJ tpahgpj;Js;s rptg;gpuhd; cikahSf;F ,ij ciuj;Js;shu;. 
       -Foe;ij fiz Neha; kUj;Jtk; 
―nrhy;ypa nrd;d $w;why; Jlu; gotpidahy; te;J 
ey;ytdUWg;gpd; rhu;e;J kUtpa Njh]j;jhNy 
my;yfrpurpy; ePuhy; md;idapd; ghypdhYk; 
fy;yf euk;gpy; jhtp fgkJ te;JrhUk;‖ 
fUktpidahYk; cWg;ig rhu;e;j Njhrj;jhYk; jiy ePuhYk;;> md;idapd; ghypd; 
Nfl;lhYk; Foe;ijapd; clypd; euk;gpy; Njhrk; jhtp fgk; Vw;gLfpwJ. 
―njhifahd fzq;fs; vy;yhk; fh;g;gr;R+L‖-(mNahj;jpjhrh; ghythflk; -193) 
 ―R+L‖vd;gij ‗clypd; ntg;gepiy‖ vd;W nfhs;Nthkhdhy; fUTw;w fhyj;jpy; 
jha;khh;fSf;F fpUkp njhw;wpdhy; Ruk; Vw;gl;L> mJ gpwf;Fk; Foe;ijiaAk; 
ghjpg;gjhf nfhs;syhk;. 
 khwhf ‗R+L‖ vd;gij gpj;jk; (m) moy; vd caph;j;jhJthf nfhz;lhy;> 
fUtpd; moy;jhJ khWghL fPo;f;fz;l tifapy; cz;lhfyhk;. 
 fytpapy; Vw;gLk; tpfw;gk;. 
 Rf;fpy> RNuhzpjq;fspd; tpfw;gk;. 
 fUTw;w jha;khh;fspd; czTKiw> nray;ghLfs; ,tw;wpd; tpfw;gq;fs;. 
fytpapy; Vw;gLk; tpfw;gk;: 
vz;nza; Nja;j;J %o;fpagpd;> clNd czT mUe;jp> cwf;fk; nfhs;tjhy; clypd; 
gpj;jNjhlk; mjpfhpf;Fk;. mNj Neuj;jpy;; cwT nfhs;Sk;NghJ cz;lhFk; fUTf;F 
fzk; cz;lhfyhk; vd;W fUjg;gLfpwJ. 
Rf;fpy> RNuhzpjq;fspd; tpfw;gk;: 
fzkhdJ> khjhgpjhf;fsp;d; ehjtpe;Jf;fSs; mlq;fpa thjhjp Njhlq;fspypUe;J 
cw;gj;jpahfp> fUg;igapd; rpRitg;gw;wp> mr;rpRtpdJ rg;jjhJf;fSk; td;ikia 
milAk; fhyj;jpy; ghjpf;fpd;wJ. (Njhlq;fs; tpUj;jp milfpd;wd). - Mjhuk;-
IPtul;rhkph;jk;  
―Rf;fpyj;jpy; RNuhzpjq; fyf;Fkd;W 
GFe;jpLk; tpahjp %d;Wk;‖- jd;te;jphp ehb E}y;. 
fUTf;F moy;jhJtpid Nrh;g;gJ Rf;fpykhFk; mjid gpd;tUk; E}y;fs; 
njspthf $Wfpd;wd. 
”ghd;ik vd;w tpe;jq;Nf A+Wk;NghJ 
   ghAklh td;dpNahL thAjhNd”;- mfj;jpah; ty;yhjp ehb E}y;. 
 
‖cd;dpa fh;g;gf; Fopahk; ntspapNy 
gd;dpa ehjk; gfh;e;j gpUjptp 
   td;dpAk; thAT khapUQ; Rf;fpyk; 
   kd;dpa rkdha; tsh;f;F KjfNk‖- jpUke;jpuk;. 
    fUtpw;F> tpe;JtpypUe;J - thjk;> gpj;jk; vd ,uz;L jhJf;fSk; cjfePh;> 
ehjk; ,tw;wpypUe;J fgKk; fpilf;fpwJ vd fUjg;gLfpwJ 
mNj ghlypy;> 
 ―cjfKjpu KWq;fdy; thAthy; 
 rpj FW kq;fq;fs; nra;J Kbj;jpLk;‖ 
   cjfkhfpa ePh;> jP kw;Wk; thAtpd; jd;ikahy; nre;ePuhf khwp kw;w 
cly;jhJf;fshd Cz;> nfhOg;G> vd;G> %is> Rf;fpyk; ,tw;iw cz;lhf;Fk; vd 
fUjg;gLfpwJ. 
     vdNt Rf;fpy> RNuhzpjq;fspd; FiwghL> cjfePhpd; FiwghL Nghd;wtw;why; 
fUtpd; caph;j;jhJfspy; xd;whd moy; ghjpg;giltjhy; fzk; Vw;gLfpwJ. 
‗fh;g;gr;R+L‘ vd miof;fg;gLtjw;Fk; mJNt fhuzk; vd fUjyhk;.  
fUTw;w jha;khh;fspd; nray;ghLfs;: 
 ―igau ty;F yhSk; grpAldpUe;j jhYk; 
 Ja;aNjhh; Fotpfl;F fzq;fSe; Njhd;Wkd;Nw‖- ghythflk;. 
fUTw;w jha;khh;fspd; czT gof;ftof;fq;fs;> nray;ghLfs; Nghd;wtw;why; 
jhapd; clypy; moy;jhJ ghjpg;gile;J mJ fh;ghraj;ijAk; jhf;Fk; vd 
[Ptul;rhkph;jk; vd;w E}ypy; $wg;gl;Ls;sJ.vdNt fUtpd; moy;jhJtpy; FiwghL 
Njhd;Wtjhy; mjd; cly; jhJf;fs; ghjpf;fg;gLfpd;wd. ,JNt ‗fh;g;gr;#L‘ vd 
miof;f fhuzkhfTk; mike;jpUf;Fk;.  
khe;j Nehapd; njhlh;r;rpahf fzk; Njhd;Wk; tpjk;: 
khe;jk;: jha; kw;Wk; Foe;ijfspd; czthjp (m) Fzthjp gof;f tof;fj;jpy; 
Fw;wk; NehpLk;NghJ Foe;ijfSf;F Njhd;Wk; nrhpkhdf; NfhshWfs;> mjidj; 
njhlh;e;j czTg;ghij njhlh;ghd cghijfSk; khe;j Neha; vd;W 
miof;fg;gLfpd;wJ. 
czTg;gof;fj;jhy; khe;jk; Njhd;Wjy;: 
 cz;Zk; cztpd; nrhpkhdj;jpw;F> 
  rkhdd; - thjk;> 
  mdw;gpj;jk; - gpj;jk;> 
  fpNyjfk; - fgk;>Mfpa %d;wpd; ,ay;ghd msT Kf;fpakhdjhFk;. 
mdw;gpj;jk;  -  czTg;nghUs;fspd; nrhpkhdj;jpy; Kjd;ik  
gq;F  tfpf;fpwJ.  
fpNyjfk; -    cz;Zk; cztpid nkj;njd nra;Ak;.  
rkhdd; -  Nkw;fz;l ,uz;ilAk; rkepiygLj;jp> rhpahd    
 nrhpkhdj;jpw;F cjTfpwJ. ,J nrayw;why; nrhpkhdNk elf;fhJ. 
ke;jhf;fpdp: 
Nkw;fz;l %d;wpy; mdw;gpj;jj;jpd; td;ik Fiwe;jhNyh> fpNyjfj;jpd; td;ik 
mjpfhpj;jhNyh> rkhdthA jd; ,aw;if epiyapypUe;J jtwpdhNyh ke;jhf;fpdp 
cz;lhFk;. mjdhy; czTg; nghUl;fs; clNd nrhpg;gpf;fhky;> thAthy; 
taw;wpiur;ry;> Flypiur;ry;> tapw;Wg;gprk; vd;Dk; ,tw;iw cz;lhf;fp neLNeuk; 
fopj;J nrhpg;gpf;;Fk;. vdNt cztpd; rhuk; clYf;F fpilf;fhky; Nghfpd;wJ. 
 
  .IaJ $bw;nwd;why;: (Iak; - caph; jhJ) 
Iaj;jpd; ,aw;if epiyfs;> mjd; kpFFzk; Nghd;wtw;iw xg;G Nehf;Fk; 
nghUl;L fPo;fz;lthW njhFf;fg;gLfpd;wJ.  
jd;ik:  
 jd;ik>nea;g;G,nkd;ik>jpz;ik 
 ke;jk;> tOtOg;G 
thOkplk;: 
 rkhdthA> ROKid 
 Mf;fpid> tpe;J 
 ehf;F> cz;zhf;F 
 nfhOg;G> kr;ir 
 FUjp> khh;G 
 euk;G> vYk;G 
,aw;ifg; gz;G: 
 epiyj;jy; 
 nea;g;G 
 fPy;fspd; mikg;gpd; fl;Lfs; 
 nghiwAilik (grp> ePh;Ntl;if;> fyf;fk;> ntg;gk; Nghd;wtw;iw nghWj;Jf; 
nfhs;Sjy;) 
Ia kpFFzk;: 
 mf;fpdp ke;jg;gly,;cg;gprk;>kpFJ}f;fk; cz;lhjy 
 tha;ePH Cwy;, iug;G> 
 Cf;fk; Fiwjy;, Uky;; 
 cly; fdkhf Njhd;WtJld; ntz;zpwj;ijAk;> Fsph;r;rpiaAk; miljy;. 
 cly; Kw;Wk; cs;s fl;Lfs; jsuy; 
mhpitah; Jaue; jd;dhy;: 
mhpit - ngz;fspd; gUtq;fspy; xd;W. 20-25 tajhdJ kfsph; kfg;NgW 
milAk; nghJthd fhyk; vd;gjhy;> ghlypy; mhpit vd;w thh;j;ijia 
Nkw;nfhz;bUg;gij czuyhk;. mg;gUtj;jpy; kfsphpd; Jd;gq;fshd 
cly;eyf;FiwT> nghUshjhuf;FiwT Nghd;wit Foe;ijfSf;F gy 
,lh;ghl;bidAk;> Fwpg;ghf fzj;jpidAk; cz;lhf;Fk;;. 
nra;a gw;GdyUe;jp nrhpry Njhle;jd;dhy;: 
gy;NtWtifg;gl;l ePhpid mUe;Jtjhy; ryNjhlq;fs; cz;lhfp epiyj;J 
fzNeha; Njhd;Wk; vd;gJ nghUshFk;.mj;jifa ePhpd; jd;ik> Fbj;jYf;F Mfhj 
ePH vd rpj;jkUj;Jtj;jpy; $wg;gl;Ls;s fUj;Jfis fhz;Nghk;. 
ePhpd; jd;ik: (rpj;jkUj;Jthq;f RUf;fk;) 
ePuhdJ kdJf;F fspg;igAk;> epiwitAk; cz;lhf;FtJ kl;Lkd;wp 
cl;nfhs;Sk; cztpid ed;wha; clypw; gutr; nra;J clw;F td;ikiaj; jUk;. 
NkYk; cz;l fbd czTg;nghUl;fis nrhpg;gpf;Fk;. ePUf;F jdpFzk; ,y;iy. mJ 
jq;Fk; ,lj;jpd; NtWghLfshNyNa ntt;NtW Fzq;fis milfpd;wJ.,jid> 
―jz;zPh; Fznky;yhe; jhd; Nfs; klkapNy 
 kz;zpd; Fzky;yhy; kw;Wz;Nlh?‖ 
- Njud; nghUl;gd;G 
Fspay; Fbj;jYf;F Mfhj ePh;: 
  ―re;jpuh jpj;jh; tsp rhuhj ePh; GOJh;f;  
   fe;jkjp NrW fdg;gpiyA - jphpe;j ePh; 
   jq;FRit apy;yh ePh; rhw;Wkpit ];ehdgh 
   dq;fSf;fh fhTwpNeh ahk;.            - gjhh;j;j Fz rpe;jhkzp 
jpq;fs;>QhapW ,tw;wpd; fjpnuhsp;;; fhw;W ,itfs; mZfhjJk;; fpUkp> Jh;ehw;wk;> 
NrW jbj;jy;> rUF cjpuy;> Ritapd;ik vd;Dk; ,itfs; nghUe;jpaJk; Mfpa 
ePh;>Fspay;> Fbj;jy; ,itfl;F MfhJ. ,ij cz;zpd; Nehia cz;lhf;Fk;. 
NkYk;> 
“Jiyahf; fpzNw fae;jpul;Lk; ”  
  - ,iwg;gpy;yh fpzw;WePh; fgg;gpzp cz;lhf;Fk;. 
“tsh;f;FQ; Ruj;ij rU$wy; ” 
    - rUF Cwpa ePh; Ruk; tsh;f;Fk;. 
“khwhf; FsNk tpahjpAz;L ”  
  - gad;gLj;jhj Fsj;JePh; tpahjp cz;lhf;Fk;.  
mt;thW gy;NtWgl;l ePhpid mUe;Jtjpdhy; ryNjhlk; Vw;gl;L  fzNeha; 
Njhd;Wk; vd;W $wg;gLfpd;wJ. 
igau ty;FyhSk; grpAldpUe;jjhYk;: 
(igau - #y;nfhz;l: ty;Fyhs; - #Yw;w ngz;fs;).  
#Yw;w ngz;fs rhptpfpj cztpid cz;zhjjhy; mth;fspd; cly;eyd; 
Fd;wp mJ Foe;ijfspd; tsh;r;rpiaAk; fzNeha; Njhd;Wtpf;Fk.; 
 
 
gpw E}y;fs; fUj;J : 
jpUts;Stehadhh; ,aw;wpa etuj;jpdrpe;jhkzp 800 y; $wpathW je;ijapd; 
Ntl;ifahy; gpz;lk; fdypy; mbgl;L fzk; tUtjhf $wg;gl;Ls;sJ. 
 ―ghuhd nfw;gntl;il kPUk; gf;Ftj;jpy; 
 Ntuhd tphpe;J ntspg; gl;L Nahdp tpOe;j njd;whw; 
 fhuhd gpz;lq; fdypyb gl;Lf; fhe;jpdpdhw; 
 $uha; fzRu nka;J nkd;Nwahd; $wpNdNk‖ 
jd;te;jphp itj;jpak; vDk; E}y; fzkhdJ G+h;tn[d;kq;fspy; nra;j jPtpidfis 
je;ijahfTk;> ,g;gpwg;gpy; nra;Ak; jPtpidfis jhahfTk; mile;J ―af; Fkhud;‖ 
gpwf;fpwhd; vd;W $WfpwJ. 
―rPhpa njhd;ik nra;j jPtpid je;ijahfg; 
  ghhpypg; gpwg;gpw; nra;j ghtNk jhajhfg; 
  Nghpar; raf; Fkhud; tpwe;jpyh fpw kj;jg;Ng 
  fhhpa nrtpypj; jhaha; „fzk;‖ ngw tsUk; ehspy;‖;….. 
fzj;jpd; tiffs;(Types): 
 gy;NtW E}y;fs; ntt;NtW vz;zpf;iffspy; fzj;jpid njhFf;fpd;wd. 
gps;isg;gpzp kUj;Jtj;jpy; $wg;gl;Ls;s fzq;fs;-64 tiffs; 
1. tspfzk;    33. mow;fzk; 
2. Ia fzk;   34. khe;j fzk; 
3. ePh;f;fzk;    35. gpuspf;fzk; 
4. #ypfzk;    36.. Ropfzk; 
5. kfhfzk;    37. CJfzk; 
6. tus;fzk;    38. nfhjpg;G fzk; 
7. tPf;f fzk;   39. gpwf; fzk; 
8. mf;fu fzk;   40. ke;jhu fzk; 
9. vhp fzk;    41. ePuhk fzk; 
10. ,uj;j fzk   42. Kf;F fzk; 
11. %y fzk;   43. Nguhk fzk; 
12. cyup fzk;   44. rpq;fp khe;j fzk; 
13. Mk fzk;   45. Rj;jp fzk; 
14. czf;F fzk;   46. ru;g;g fzk; 
15. cd;Nuhffzk;   47. rpj;ufzk; 
16. CJkhe;j fzk;   48. Rufzk; 
17. fug;ghd;fzk;   49. jdpRufzk; 
18. fsp;fzk;    50. mjpRu fzk; 
19. Fly;Nrhif fzk;  51. J}q;F fzk; 
20. FlNyw;w fzk;   52. njw;fj;jp fzk; 
21. vhp fzk;    53. njw;fj;J khe;j fzk; 
22. ,uj;j fzk   54. ePuhk;g fzk; 
23. %y fzk;   55. gl;rp fzk; 
24. kNfe;jpu fzk;   56. ghy fzk; 
25. ke;jhu fzk;   57. %yhjhu fzk; 
26. Nkf fzk;    58. thA fzk; 
   27. thNte;jpu fzk;       59. thyre;jpu fzk; 
   28. tp\ fzk;    60. tp\ePu; fzk; 
   29. tp\ghffzk;    61. tp\ khe;j fzk; 
   30. tpujp fzk;    62. tPq;F fzk; 
   31. ntg;G fzk;        63. Fd;wp mf;fu fzk; 
   32.nghUK fzk;              64. KbNyhf fzk; 
Mj;kul;rhkph;jk; vd;Dk; itj;jpa rhuq;f rq;fpufk; - fe;jrhkp Kjypahh;;                                      
1. thj fzk;   13. gpj;j fzk; 
2. rpNyj;Jk fzk;   14. khe;j fzk; 
3. ePh;f; fzk;   15. gpusp fzk; 
4. #iyf; fzk;   16. Rop fzk; 
5. kfh fzk;   17. CJ fzk; 
6. twl;rp fzk;   18. nfhjpg;G fzk; 
7. tPf;f fzk;   19. gpwf; fzk; 
8. Mkf; fzk;   20. twl;rp fzk; 
9. Kf;F fzk;   21. Nghh;f; fzk; 
10. ,uj;j fzk;   22. er;R khe;j fzk; 
11. CJ khe;j fzk;   23. vhp fzk; 
12. ke;jhu fzk; 
mNahj;jpjhrh; ghythflk; 24 tiffs; - gf;fk; - 180; gjpg;G 1992 
1. tspfzk;     
2. mow;fzk; 
3. Ia fzk;    
4. khe;j fzk; 
5. ePh;f;fzk;     
6. gpuspf;fzk; 
7. #ypfzk;     
8. Ropfzk; 
9. kfhfzk;     
10. CJfzk; 
11. tus;fzk;     
12. nfhjpg;G fzk; 
13. tPf;f fzk;    
14. gpwf; fzk; 
15. me;jf fzk;    
16. ke;jhu fzk; 
17. vhp fzk;     
18. ePuhk fzk; 
19. Mk fzk;   
20. Kf;F fzk; 
21. %y fzk;    
22. Nguhk fzk; 
23. uj;j fzk;    
24. rpq;fp khe;j fzk; 
guuhr Nrfuk; ghyNuhf epjhdk; - 18 tiffs; 
1. thj fiz        10. gpj;j fiz 
2. Ruf; fiz        11. mj;jpRu fiz 
3. twl;fiz        12. thyre;jpufiz 
4. kNfe;jpu fiz   13. J}f;F fiz 
5. mdw; fiz   14. tPq;F fiz 
6. ntSg;Gfiz   15. rj;jp fiz 
7. ,uj;j fiz   16. %yf;fiz 
8. fUq;fiz   17. kQ;rl; fiz 
9. epyf; fiz   18. ntg;G fiz 
  gps;isg;gpzp thflk; - 8 tiffs; 
1. ePh; fzk;    5. tus; fzk; 
2. %yfzk;    6. rPjfzk; 
3. ,ja fzk;   7. kfhfzk; 
4. kyf;fzk;   8. Fz;lypa fzk; 
[Ptul;rhkph;jk; 8 tiffs; 
1. #ypfzk;    5. Kf;F fzk; 
2. Mkfzk;    6. Njiufzk; 
3. kfhfzk;    7. Ropfzk; 
4. fopfzk;    8. tws;fzk; 
rhk;grptk; gps;is mfuhjpapd;gb  
fzkhdJ> khjh gpjhf;fspd; ehj tpe;JFs;slq;fpa thjhjp Njhlq;fspdpd;W 
cw;gj;jpahfpf; fUg;ghraj;Jr; rpRitg; gw;wp mr;rpRtpdJ vOtifj; jhJf;fSk; 
td;ikailAq; fhyj;J mij Nehahy; tUe;jr; nra;Ak; Neha;.,J jkpo; itj;jpag; 
gb Nehapd; Fzk; Fwp ,itfspd; ngahpl;L mNdf tpjkha;f; nfhs;sg;gLk;. 
fzj;jpd; nghJ Fzq;fs; : 
ghy thflk; $Wk; Nehapd; Fzq;fs; 
 Foe;ijfSf;F khe;j Neha; gyKiw te;J Kw;wpYk; Fzkilahky; 
,Ug;gjhy; ,e;Neha; cz;lhFk;. 
 gpj;jkhdJ mjpfkhfp thAf;fs; jd; Ntiyia nra;a Kbahky; 
jLj;JtpLk;. mjdhy; Foe;ijfspd; clypy; Vw;gl;l #L ve;NeuKk; tplhJ 
fhZk;. 
 Ruk; fha;jy; 
 ,Uky; 
 %r;R thq;Fjy; 
 cly; Nrhh;tiljy; 
 tapW Nehjy; 
 tapW fopjy;  
- kyk; vz;nza; frpthdjhf ,Uf;Fk; 
- rPjkhf> ,uj;jkhf (m) ,uj;jKk;> rPjKk; fye;J  
Ngjpahjy; 
- ghy; Nghy ntz;zpwkhf fopjy; 
- Cz; fOtpa jz;zPh; Nghy; Ngjpahjy; 
- kytha; vhpr;ry; 
- kyk; ntl;ilahjy; (kyr;rpf;fy;)  
 cr;rpapy; Fop tpOjy; 
 Kfk; Nrhh;tile;J fhZjy; 
 Fuy; fk;kyhf NgRjy; 
 if> fhy;> Kfk; twz;L fhZk; 
 mdy; tPRtJ Nghd;W cl;Ruk; fhzy; 
 tha;ehw;wk; 
 khh;G $k;G Nghy; vOk;gp fhzy; 
 ePh; RUq;fy; 
fzj;jpy; xd;Wld; xd;W njhlh;Gfsw;w gy FwpFzq;fs; njhFg;ghff; 
fhzg;gLfpd;wd. mjdhy; fzj;jpy; gy Neha; epiyfs; ,Ug;gjid mwpayhk.; 
NkYk; nghJf;FwpFzq;fis gpujhdkhff; nfhz;L> fzj;jpd; rpwg;G 
Fzq;fSld; nghUj;jp (fzj;jpd; tiffs;) Nehapid fzpj;jy; rpwg;ghdjhFk;.  
gpw E}y;fspy; fhZk; fzj;jpd; nghJFzq;fis mwpe;J nfhs;Sk;NghJ> 
Nehapid Fwpj;j njspthd xg;GNehf;F nra;a KbAk; vd;gjhy; mjidAk; 
fhz;Nghk;;. 
mgpjhd rpe;jhkzp $Wk; Nehapd; Fzq;fs;: 
khh;gpy; tPf;fk;,cl;Ruk;Ruk;,twz;l kyk; 
[Ptul;rhkph;jk; $Wk; Nehapd; Fzq;fs;: 
 tha;ehw;wk; 
 jiyRw;wy; 
 cs;Ruk; (my;yJ) 
 xU Ntis ntspRuk; (my;yJ) 
 tapw;wpd; Nky; RLjy; 
 kaf;fk;&twz;l kyk 
,f;Fzq;fs; rfy fzj;jpw;Fk; nghJthf tUk; vd mwpf. 
cs;Ruk; Fwpj;j tpsf;fk;: 
mf];jpah; RuE}y; 300 - ‗rpj;jkUj;Jtk; - nghJ‘ gf;fk; 57 - 6k; gjpg;G vd;w 
E}ypy; ‗RukNj fizajhFk;‖ vd $wg;gl;Ls;sJ. 
mjd; tpsf;fj;jpy; Foe;ijfSf;F Njhd;Wfpd;w vd;GRuk;> moy; Ruk;> 
khe;jRuk; Nghd;witfs; Foe;ijfis tUj;jkilar; nra;J> gpd;dh; fiz 
Nehapid gpwg;gpf;Fk;. 
fzk; - Ruk; njhlh;G : 
 ‗fiz Nehapy; cl;Rukhf fhAk;‖ 
      rpj;jkUj;Jtk; - nghJ 
 ‗fizapy; fhe;js; kyh; Nghd;w Ruk; fhZk;‖ 
 Nkw;fz;l Nkw;Nfhs;fs;> fzj;jpy; Ruj;jpw;Fk; gpw Neha; epiyfspy; fhZk; 
Ruj;jpw;Fk; NtWghL cz;L vd;gij njspthf $Wfpd;wd. 
(fhe;js; kyh; vd;gJ jP G+jj;Jld; njhlh;G nfhz;lJ. me;j kyhpd; my;yp 
,jo;fs; RUf;fkhdjhf fhZk.; fiz NehapYk;> njhlh;e;J cl;Ruk; cs;s 
Foe;ijfs; cly; Nrhh;tile;J fhZtjhf nghJ FwpFzj;jpy; Fwpg;gplg;gLtJ 
rpwg;ghFk;). 
‗cl;Ruk;‖ vd;gJ gpw Ruq;fspypUe;J NtWgl;lJ. ,r;Ruk;> cly; td;ik 
Fiwe;j Ngh;f;F ntspf;F njhpahky; clypd; cs;Ns jfpj;J> Ruk; ,Ug;gJ Nghd;W 
fhzg;gl;L> Nrhfk;> kdj;jsh;r;rp> iffhy; Xa;r;ry;> cztpy; tpUg;gkp;d;ik> 
tha;f;Fkl;ly;> vg;NghJk; Ruk; fha;tJ NghypUj;jy;> cly; nkype;J nfhz;Nl 
nry;Yjy; vd;Dk; Fwp Fzq;fis gpwg;gpf;Fk;. 
        - rpj;jkUj;Jtk; nghJ    .  
஧ா஬யாகடம் நூ஬ின்஧டி ஥ீர்க்கணநாந்தத்தின் கு஫ிகுணங்கள்:  
“இருமு மூக்கில் ஥ீர்யடிம௃ம் 
 இடடனில் சுபங்காம௃ம் 
ப஧ாருநி யனிறு இட஫ச்சலுண்டாம் 
 ப஧ாதப் ஧஬யித நாய்க்கமிம௃ம் 
பசாருகுங் கண்ணும் உடம்புமுகம் 
 பசார்ந்து தட஬ம௃ம் புபட்டலுண்டாம் 
       நருயி நனக்கம் உண்டாகும்  
       யருகு ஥ீர்க்கண நாந்தமுபந   
   -஧ா஬யாகடம் குமந்டத நருத்துயம்  pg.- 179  
ஆத்நபட்சாநிர்தம் என்னும் டயத்தின சாபங்க நூ஬ின்஧டி ஥ீர்க்கணநாந்தத்தின் கு஫ிகுணங்கள்: 
இருநல் மூக்கில் ஥ீர்யடிம௃ம்   
இடடனில் சுபங்காம௃ம் 
ப஧ாருநி யனிறு இட஫ச்சலுண்டாம் 
஧஬யித நாய்க்கமிம௃ம் 
நனக்கம் உண்டாகும் 
கண், உடம்பு, முகம்  பசார்ந்து ப஧ாகும். 
Neha; fzpg;G: (Diagnosis) 
Piniyari muraimai is a method of diagnosing a disease. Siddha system has a very 
unique method of diagnosis. 
  ―Pini‖ means    =   Disease 
  ―Ari‖ means  = Identify 
  ―Muraimai‖ means   =   Method. 
This is based upon three main principles and Envagai Thervugal. The three main 
principles are, 
1. Poriyal arithal (Inspection) 
2. Pulanal arithal ( Palpation) 
3. Vinathal ( Interrogation) 
 Physician‘s ‗Pori‘ and ‗Pulan‘ are used as tools for examining the ‗Pori Pulan‘ of the 
patients. The above principles correspond to the methodology of 1.Inspection, 2.Palpation 
and, 3.Interrogation in modern medicine, in arriving a clinical diagnosis of the disease. 
Poriyaal arithal: (Inspection) 
Porigal are considered as the five senses of perception namely, 
1. Nose  
2. Tongue   
3. Eye    
4. Skin  
5. Ear 
Pulanal arithal: (Palpation) 
  Pulangal are functions of five senses. They are, 
1. Smell  
2. Taste 
3. Vision 
4. Sensation of Touch                                                                                                                                                                                                                                                                                                                                    
5. Hearing. 
Vinathal: (Interrogation) 
Vinathal is asking the information regarding the history of the disease, its clinical 
feature etc., from the patient or his close relatives who are taking care of him/her.     
 rpj;j kUj;Jtj;jpd; Neha;fzpg;gpy; gpd;tUk; fhuzpfs; Kf;fpa gq;F 
tfpf;fpd;wd. 
Nehahspiar; rhh;e;jJ 
1. caph; jhJf;fs; (Kf;Fw;wk;) 
2. cly; jhJf;fs; (VO clw;fl;Lfs;) 
3. vz;tifj; Njh;T  
Nehahspiar; rhuhjJ 
4. nghOJ 
rpWnghOJ    - itfiw> tpbay;> vw;ghL> ez;gfy;> khiy> ahkk; 
        ngUk;nghOJ  - fhh;> $jph;> Kd;gdp> gpd;gdp> ,sNtdpy;> KJNtdpy; 
5. Itif epyq;fs; : FwpQ;rp> Ky;iy> kUjk;> nea;jy;> ghiy. 
Nkw;$wpa fhuzpfspd; khWghLfis xd;Wld; xd;W xg;gpl;L Neha; 
fzpf;fg;gLfpwJ. 
1. caph; jhJf;fs; (Kf;Fw;wk;) 
“஥ீர்கணநாந்தத்தில் Kf;Fw;w tpfw;gk; 
thjk;> gpj;jk;> fgk; Mfpa %d;W jhJf;fspy; rkr;rPH epiyapy; cz;lhFk; 
NtWghLfis Nehahf cw;gj;jpahfpwJ. 
(m)  ‘eLq;fpaNjhh; gpj;jkJ Nfhgq; nfhz;L 
     ey;ythAit gw;wp aOj;jpf; nfhs;Sk;”   - ghy thflk; 
Kjypy; gpj;jNjhlk; ghjpg;gile;J (jd;dpiy tsh;r;rp mile;J) gpd;G 
tspFw;wj;jpd; njhopiyAk; (Ntw;Wepiy tsh;r;rp mile;J) ghjpg;gjhf nfhs;syhk;. 
 ,Nj fUj;ij ‘ke;jkyhJ thAtuhJ” -; vd;w Njud; Nrfug;gh ghlyhy; 
ke;jj;jpdhy; thA cz;lhFk; vd mwpayhk;. NkYk; khe;jk; (ke;jk;) vd;gJ 
gpj;jj;jpd; jd;dpiy tsh;r;rp Fzk; vd mwpaNtz;Lk;. 
 (M)  ‘IaJ $bw; nwd;why;”   -  ghy thflk; 
,jd; nghUs; Iaf;Fw;wk; jd;dpiyapy; tsh;r;rp miljy; vd;gjhFk;  
,Nj fUj;ij ‘fgj;jpidad;wp fhrRthrk; fhzhNj” - vd;w Njud;Nrfug;gh 
ghlyhy; Iaf;Fw;wj;jpd; jd;dpiy tsh;r;rpad;wp fzj;jpd; FwpFzkhd fhrk;> 
Rthrk; tuhJ vd mwpayhk;. moy; Fw;wk; jd;stpy; kpFe;J thAit gw;wp mOj;jpf; 
nfhs;Sk;. mjdhy; clypy; mjpfg;gl;l moy; jzptjw;F topapy;yhky; Foe;ijf;F 
mjpfkhf #L cz;lhfp cly; fdfdg;G Vw;gLfpd;wJ. 
 
 
2. cly;jhJf;fspd; epiy: 
cz;lcztpd; md;drhukhdJ Flypy; cwpQ;rg;gl;L clw; jhJf;fshd 
rhuk;> nre;ePh;> Cz;> nfhOg;G> vd;G> %is> Rf;fpyk; (m) RNuhzpjk; Nghd;wtw;iw 
Nghlzpf;fpd;wJ vd cly;jj;Jt E}y;fs; $Wfpd;wd. 
 ‘je;jpL euk;g njy;yhe; jhq;fpNa A+izg; gw;wp 
 ce;jpL kpuj;jnky;yh kKnjd Tz;Z kd;Nw” 
  - guuhrNrfuk; - ghyNuhf epjhdk; ghly;: 269 
vd;w ghlyhy; fiz Neha; cly; jhJf;fis ghjpf;Fk; vd mwpayhk.; 
fizapy; cly; jhJf;fs; Nghlzpf;fg;gLtjpYk;> cUthf;fj;jpYk; rpukk; 
Vw;gLfpwJ vd;gjhy; Neha; jPtpuj;jpw;F Vw;g midj;J jhJf;fSk; (Rf;fpy> 
RNuhzpjk; cs;gl) thpirahf xd;wd;gpd; xd;whf ghjpg;gilAk; vd fUjg;gLfpwJ. 
Rf;fpyk;> RNuhzpjk; ,tw;iw Neubahf tpe;J> ehjk; vd;W nghUs; nfhs;shky;> 
cly; nry;fs; kw;Wk; cWg;Gfs; jd;idnahj;j cUtg; ngUf;fpw;F Kjyha; epw;Fk; 
cly; jhJ vd nghUs; nfhs;tJ rpwg;ghFk;.  
3. vz;tifj; Njh;Tfs;: 
nghwp> Gyd;fshy; mwpjy;> tpdhjy; Nghd;witfspd; %yk; kUj;Jth; 
mwpe;jtw;iw vz;tifj; Njh;Tfs; %yk; cWjpgLj;j Ntz;Lk;. 
 ‘ehb ];ghprk; eh epwk; nkhop tpop 
 kyk; %j;jpukpit kUj;JtuhAjk;” 
- Neha;ehly; Kjy; ghfk;        
   ’Njba tpahjpf; nfy;yk; Njfj;jpy; ghpl;irAz;L 
 $bNa epw;Fnkl;L ghpl;irahq; $wf;NfsPh; 
 ehbNa njhl;lhw; Njfk; %j;jpuk; thh;j;ij fz;fs; ehf;F 
 ghbNa kyryq;fs; gy tz;zk; ghh;j;Jf; nfhs;Ns 
                                                                -  rpj;j kUj;Jtkzpfs; 
 Nkw;$wpa ghlypd; %yk; ehb> ];ghprk;> eh> epwk;> nkhop> tpop> kyk;;> %j;jpuk; 
Mfpad kUj;Jthpd; MAjk; Nghd;wit vd mwpayhk;. 
1. ehb 
       vz;tifj; Njh;Tfspy; gpujhdkhdJ. gpzpapid ehbahywpe;J 
kUe;J}l;LjNy rpwe;jJ vd;W rpj;j kUj;Jtk; $Wfpd;wJ. Mdhy; Foe;ijfspy; 
ehbeil rhpahf Njhd;whJ vd;gij fPo;fz;l ghlyhy; mwpayhk;. 
 ’nfhz;blNt faNuhfp fhrNuhfp 
 Fwpg;ghf rpw;wpd;gk; nra;j Ngh;fs; 
 mz;blNt jhpj;jpuh;fs; tpUj;jh; ghyh; 
 nfhz;blNt ,th;fspd; cWg;gpd; jhJ 
 $wNt KbahJ vth;f;Ff; fpl;Lk;.” 
- Neha;ehly; Neha; Kjy;ehly; jpul;L 
vdpDk; fzj;jpy; gpj;jFw;wk; Kjd;ikahf ghjpj;J gpd; thj> fg 
Fw;wq;fSk; ghjpg;gjhy;> fPo;fz;l ehbeilahdJ Njh;thsuhy; ghpNrhjpj;J 
vOjg;gl;lJ. 
- gpj;jfgk; 
- gpj;jthjk; 
   -  thjgpj;jk; 
 
2. ];ghprk;: 
Nehahspapid njhl;L ghh;j;jypd; %yk; czug;gLk; FwpFzq;fs; MFk.; 
஥ீர்க்கணநாந்த Nehapy; fPo;f;fhZk; FwpFzq;fs; mt;thW czug;gl;lJ. 
- tapWtyp;> Ruk;> cl;Ruk; 
3. eh 
 Nehahshpd; ehf;fpid ghh;j;J czug;gLk; ஥ீர்க்கணநாந்த Nehapd; 
FwpFzq;fshtd. 
- nre;ePh;j;jhJ Fiwe;J fhZjiy> eh ntspwpl;L ,Uj;jyhy; mwpayhk;. 
4. epwk;: 
 ஥ீர்க்கணநாந்த Nehapy; clw;fl;Lfs; td;ik Fiwe;Js;sij mwpa 
epwg;ghpNrhjid gad;gLk;. 
 Njhypd; epwk;  -  ntspwpf;fhZjy; 
       fWj;Jf;fhZjy; 
 eh> fz;  -  ntspwpf;fhZjy; 
5. nkhop: 
஥ீர்க்கணநாந்த Neha; Foe;ijfspy; fgk; mjpfhpf;Fk; fhuzj;jhy; Fuy;fk;ky; 
Njhd;wp jho;e;J NgRth;. 
6. tpop: 
 tpopr;Nrhjidapy;> ஥ீர்க்கணநாந்த Nehapd; fPo;f;fhZk; FwpFzk; czug;gl;lJ. 
- fPopik ntspwpf;fhZjy; 
7. kyk;: 
 ஥ீர்க்கணநாந்த Foe;ijfspy;> tpdhjypd; %yk fPo;fz;l FwpFzq;fs;mwpayhk;. 
- fopr;ry; 
- kyr;rpf;fy; 
8. %j;jpuk;: 
Foe;ijfspy; Ngjp ,Ue;jhy; clypd; ePh;j;Jtk; Fiwe;J ePh;;;;tuj;J Fiwe;J 
fhZk;. 
ePh;f;Fwp: 
  ‘te;j ePh; fhpnail kzk; Eiu vQ;rnyd; 
   iwe;jpaYsit aiwFJ KiwNa” 
    - Neha; ehly; Kjy; ghfk; 
 ePhpy; epwk;> kzk;> Eiu> vil> vQ;ry;> Mfpatw;iw Nehf;f Ntz;Lk;. 
nea;f;Fwp: 
Foe;ijfspd; ehbeil rhpahf fzpg;gjpy; rpukk; cs;sjhy;> nea;f;Fwp 
ghpNrhjid %yk; Nehahsh; vf;Fw;wj;jhy; ghjpf;fg;gl;Ls;shh; vd;gjid fzpf;fyhk;. 
 fzNehahspapd; rpWePiu Nrhjid tl;bypy; Cw;wp xsp kpFe;j ,lj;jpy; ePhpd; 
miyapy;yhj NghJ ey;nyz;nzaj;;Jsp tp;l;L ghh;f;fg;gl;lJ. 
rpyhpy; Mop Nghy; (Nkhjpuk;) gutpAk;> rpyhpy; Kj;JNghy; epd;Wk; fhzg;gl;lJ. 
 ‘muntd ePz;bd; thjk; 
 MopNghw; gutpd; gpj;;jk; 
 Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
                          - Neha; ehly; Kjy; ghfk; 
 
kUj;Jtk; 
1. Ntw;Wepiy tsh;r;rpaile;j gpj;jj;jpid jd;dpiyg;gLj;j Ntz;Lk; 
2. jd;dpiy tsh;r;rpaile;j Iaj;jpid rkg;gLj;j Ntz;Lk; 
3. gpj;jFw;wj;jhy; ghjpg;gile;Js;s thjj;jpidAk; rhpg;gLj;j Ntz;Lk;. 
4. td;ik ,oe;j clw;fl;Lfis td;ik milar;nra;Ak; tifapy; kUe;jspf;f 
Ntz;Lk;. 
Keeping in mind the need for bringing out an effective therapy for 
Neerkanamantham from Siddha system of Medicine, I have undergone this dissertation 
work with sirupulladi ennai. 
The dosage of medicines for the children of age 3 to 7 years  is 1.6 ml (b.d) 
  
Line of Treatment: 
 Siddha treatment is not only for complete healing but also prevention and 
rejuvenation. Saint Thiruvalluvar says about physician‘s duty, study the disease, study the 
cause, treat subsiding way and do what is proper and effect. 
 ―Neha; ehb Neha; Kjy; ehb mJ jzpf;Fk; 
 tha;ehb tha;g;gr; nray;‖. 
 ―cw;whd sTk; gpzpasTq; fhyKq; 
 fw;whd; fUjpr; nray;‖. 
    - jpUf;Fws; 
So it is essential to know the disease, the etiology, the nature of patients, severity of the 
illness, the seasons and the time of occurrence. 
Line of treatment is as follows. 
1. Kaappu (Prevention) 
2. Neekkam (Treatment) 
3. Niraivu (Restoration) 
Kaappu (Prevention):  
Prevention and cure of the diseases are the basic principle of any medical system, but 
prevention is the main aim of Siddha system. Siddhars have described general preventive 
measures and special measures. (Which are applicable to diseases of certain organs) 
            And especially in Balavagadam, the preventive measures are explained in detail. 
Prevention of the disease of the child starts from the conception and goes on as the child 
grows up in intra uterine life and after delivery.  Siddhars have dealt elaborately with the diet 
of pregnant women, her habit, the medicine to be taken in every month, her psychological 
conditions, and surroundings etc. 
Neekam: (Treatment) 
The aim of treatment is based on, 
To bring the three thodams into normal equilibrium state, emetics and purgatives are 
given. But considering physical condition of the children administration of purgatives and 
emetics is excluded from line of treatment. 
Niraivu: (Restoration) 
1. Reassurance of disease recovery was given to all patients. 
2. All the patients are advised to follow the life style that provides a disease free life.  
Pathiyam (Diet): 
 During the course of treatment, the drug is administered to the patients according to 
the nature of disease and the patients were advised to follow certain restrictions regarding 
diet and physical activities. 
 This type of medical advice in siddha system of medicine is termed as ―Pathiyam‖. 
Importance of pathiyam is quoted as follows. 
 ‗gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
 gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy;  
 gj;jpaNk ntw;wpjUk; gz;bjHf;F Mjypdhy; 
 gj;jpaNk cj;jpnad;W ghH‖   - NjiuaH ntz;gh 
The patient with Neerkanamantham are advised to avoid cool drinks, cold water and 
exposure to chill weather and allergens (dust, psollens, and odours)  
 During the course of treatment according to the drug administered to the patients and 
nature of the disease, the patients were advised to follow certain precautions regarding diet 
and physical activities. This type of medical advice in Siddha system of medicine is termed as 
Pathiyam. 
Siddhars advice regarding the diet regimen for Kaba patients is explained below: 
fj;jhp 
Nga;Gly; 
ghfy; 
fsh 
mj;jpf;fha; 
gPHf;;fq;fha; 
fjypj; jz;L 
Ks;sq;fp 
 ―fj;jhp Nga;Gly; tiu apUghfy; gUq;fsh fz;lfhhp 
 mj;jpf; fha;fSk; tUf;ifkhgaw;iw fiuahy; gPHf;fUk; - gpQ;RNtH 
 nkha;j;j R+uzq; fjypj; jz;Lfisg; g+Ksq;fp KUf;fUk;Gk; 
 mj;jpg; g+rpdpf; fhaUs;sp ts;spAq; fgj;NjhHf; fhzkhNk‖ 
‗Ntis kzj;jf;fhsp nkd; rPij rf;utHj;jp 
 gPis triy Rf;F ngz;Rzq;fs; - Ntisapiy 
 nre;jspH fisf; fPiu nra;tH fgNjfH epjk; 
 te;jdpAzj;jhd; kfpo;e;J‖. 
                       -gjhHj;jFz rpe;jhkzp 
 
Prevention methods: 
 The patients were advised, 
 To find out which agent makes allergy and avoid them. 
 To avoid contaminated food and water and avoid cold weather. 
 To avoid cold food stuffs, beverages etc  &To take highly nutritious diet  
 like vegetable soups to get their immunity developed 
 
 
 
 
  
 
 
 
 
 
 
MORDERN REVIEW 
 
 
 
 
 
 
 
 
  
3.2 MODERN ASPECTS 
The Respiratory tract is divided into the Upper respiratory tract and Lower respiratory 
tract. Upper respiratory tract includes the nose and nasal passages, para nasal sinuses, the 
pharynx, and the portion of the larynx above the vocal cords. Lower respiratory tract includes 
the portion of the larynx below the vocal cords, trachea, bronchi and bronchioles, alveolar 
sacs and alveoli. The lungs can be included in the lower respiratory tract. 
 
 
Anatomy of the Upper Respiratory Tract: 
 
 
Nasal Cavity: 
It form the main external opening for the respiratory system and are the first section of the 
body‘s airway the respiratory tract through which air moves. The nose is a structure of the 
face made of cartilage, bone, muscle, and skin that supports and protects the anterior portion 
of the nasal cavity.  
Most of the nose is concerned with filtering and providing a passage for air on its way to the 
lungs. The walls of the nasal cavity enable both these functions. In particular, the nasal 
conchae are filled with mucosal respiratory membranes coated in cilia-tiny hair-like cells that 
act to move waves of mucus toward the throat. These protections trap inhaled bacteria, dirt, 
viruses, and chemical particles in the mucus. The cilia and swallowing action then serve to 
sweep the allergens and infectious agents into the back of and down the throat for destruction 
(digestion) in the stomach. 
These olfactory sense organs are located beneath the bridge of the nose atop the nasal cavity. 
These organs, the olfactory membranes, are to be found in two clefts there and can be 
identified as a small grey or yellow patch of tissue. 
Para Nasal Sinuses: 
The sinuses of the face, sometimes called the para nasal sinuses, are air pockets within the 
bones of the skull located behind and beside the nose, cheeks, and eye sockets.  
Pharynx: 
The pharynx, also known as the throat, is a muscular funnel that extends from the posterior 
end of the nasal cavity to the superior end of the esophagus and larynx. The pharynx is 
divided into 3 regions: the nasopharynx, oropharynx, and laryngopharynx.  
 
 
 
Naso Pharynx:  
The Naso pharynx is located above the soft palate. It communicates with the nasal cavity and 
provides a passageway for air during breathing. The eustachian tubes, which connect the 
pharynx with the middle ears, open through the walls of the Naso pharynx. 
Oropharynx:  
The oropharynx, or pharynx, is a passage that connects the back of the mouth and the nose to 
the esophagus. This muscular tube, which is lined with mucous membranes, is a part of the 
respiratory and the digestive systems. The top section of the pharynx is an air passage that 
connects the nasal cavity to the region behind the soft palate of the mouth. The middle 
section is a passage for both air and food and ends below the tongue. The lowest section is for 
food only and lies behind and to each side of the larynx, or voice box, merging with the 
esophagus. The average person breathes in about 13 million cubic feet of air in a lifetime. 
The air coming from a sneeze may reach a speed of 100 miles per hour. 
Laryngopharynx: 
The laryngopharynx is where both food and air pass. It can be found between the hyoid bone 
and the larynx and esophagus, which helps guide food and air where to go. It is a part of the 
pharynx. A smooth mucous membrane covers the side and back walls. At the back of the 
larynx, the anterior wall of the laryngopharynx exists. 
Epiglottis: 
The epiglottis is a flap of elastic cartilage that acts as a switch between the trachea and the 
esophagus. Because the pharynx is also used to swallow food, the epiglottis ensures that air 
passes into the trachea by covering the opening to the esophagus.  
Larynx: 
Larynx is a tough, flexible segment of the respiratory tract connecting the pharynx to the 
trachea in the neck. It plays a vital role in the respiratory tract by allowing air to pass through 
it while keeping food and drink from blocking the airway. The larynx is also the body‘s 
―voice box‖ as it contains the vocal folds that produce the sounds of speech and singing. 
The Upper respiratory tract includes the nasal passages sinuses pharynx, larynx, which serves 
as gateways to the trachea, bronchi, and pulmonary alveolar spaces. URTI range from 
common cold typically a mild self limited cattarhal syndrome of nasopharnyx to life 
threatening illnesses such as epiglottis. Viruses account for most URIs. Bacteria primary 
infection or super infection also causes URTIs. 
 Upper Respiratory Tract Infection Causing organisms: 
The various infection causing organisms in upper respiratory tract are as follows 
 Rhinoviruses 
 Influenza viruses 
 Parainfluenza viruses 
 Respiratory syncytial virus 
 Streptococcus  
 Haemophilusinfluenzae 
UPPER RESPIRATORY TRACT INFECTION 
The various diseases that are categorized under upper respiratory tract infections are 
 Common Cold 
 Sinusitis 
 Rhinitis 
 Adenoid  
 Tonsil Hypertrophy 
 Pharyngitis 
 Laryngitis 
 
1. COMMON COLD (ACUTE NASOPHARYNGITIS) 
The common cold (redirected from Acute viral nasopharyngitis) is a viral infection of the 
upper respiratory system, including the nose, throat, sinuses, eustachian tubes, trachea, larynx 
and bronchial tubes. Although more than 200 different viruses can cause a cold, 30-50% is 
caused by a group known as rhinoviruses. Almostall colds clear up in less than two weeks 
with out complications.Children may have up to 12 colds per year. 
Description 
Colds, some times called rhinovirus or coronavirus infections, are the most common illness to 
strike any part of the body. It is estimated that the average person has more than 50 colds 
during a lifetime. Anyone can get a cold, although preschool and grade school children catch 
them morefrequently than adolescents and adults. Repeated exposure to viruses causing colds 
creates partial immunity. Treating symptoms of the commoncold has given rise to amulti-
million dollar industry in over-the-counter medications. 
Cold season begins in early autumn and extends through early spring. Although it is not true 
that getting wet or being in a draft causes a cold (a person has to come in contact with the 
virus to catch a cold), certain conditions may lead to increased susceptibility. 
These include: 
 fatigue and overwork 
 emotional stress 
 poor nutrition 
 smoking 
 living or working in crowded conditions 
Colds make the upper respiratory system less resistant to bacterial infection. Secondary 
bacterial infection may lead to middle ear infection, bronchitis, pneumonia, sinus infection, or 
strepthroat. People with chronic lung disease, asthma, diabetes, or a weakened 
immunesystem are more likely to develop these complications. 
Causes and symptoms 
Colds are caused by more than 200 different viruses. The most common groups are 
rhinoviruses and coronaviruses. Different groups of viruses are more infectious at different 
seasons of the year, but knowing the exact virus causing the cold is not important in 
treatment. 
People with colds are contagious during the first two to four days of the infection. Colds pass 
from person to person in several ways. When an infected person coughs, sneezes, or speaks, 
tiny fluid droplets containing the virus are expelled. If these are breathed in by other people, 
the virus may establish itself in their noses and airways. 
The common cold is characterized by rhinorrhea, sore throat, cough, fever, malaise, often a 
lingering mucopurulent nasal discharge,mild diarrhea. 
Sinusitis 
Sinusitis is an inflammation of the sinuses that can be caused by viruses, bacteria, fungi, 
allergies, or even an autoimmune reaction. 
Behind the bones of the face there are hollow spaces filled with air; these lead to the nose 
cavity and are called the sinuses. Sinuses have the same mucous membrane lining as the 
nose. The membrane produces a slimy secretion (mucus), keeping the nasal passages moist. 
The mucus traps dirt particles and germs. Sinusitis is an inflammation of the paranasal 
sinuses. The inflammation could be caused by a virus, bacteria, or fungus.  The infection may 
also be the result of an allergic or autoimmune reaction - when the immune system attacks 
healthy cells. It is often referred as rhino sinusitis, because an inflammation of the sinuses 
nearly always occurs with inflammation of the nose (rhinitis). 
Types: 
 Acute, which lasts up to 4 weeks 
 Subacute, which lasts 4 to 12 weeks 
 Chronic, which lasts more than 12 weeks and can continue for months or even years 
Acute sinusitis 
Acute sinusitis is most often caused by the common cold, which is a mild infection 
caused by a virus. In the majority of cases, home remedies are suitable treatments. However, 
if the sinusitis continues, it can lead to serious infections and complications.  
Typically, with acute sinusitis, the patient's sinuses become inflamed and swollen. This 
stops the drainage and causes a build-up of mucus 
Acute sinusitis signs and symptoms 
 Facial pain and pressure 
 Blocked nose 
 Nasal discharge 
 Poor sense of smell 
 Congestion 
 Cough 
Subacute sinusitis 
This type of sinusitis refers to an acute sinusitis that has not got better. Symptoms will 
be similar to acute sinusitis, possibly less severe. 
Chronic sinusitis 
Chronic sinusitis is usually caused by an infection. However, it can also be caused by 
nasal polyps (growths in the sinuses), as well as a deviated septum. 
As with acute and sub-acute sinusitis, the sinuses become inflamed and swollen, causing 
blockage and mucus build up. The patient may find it hard to breathe through the nose and 
might experience facial pain and a headache.  
Chronic sinusitis signs and symptoms 
The following signs and symptoms may have been present for at least 8 weeks: 
 Congested, puffy face 
 Blocked nose 
 Nasal cavity has pus 
 A high temperature (fever) 
 Nasal discharge 
Rhinitis 
Rhinitis is inflammation and swelling of the mucous membrane of the nose, characterized by 
a runny nose and stuffiness and usually caused by the common cold or a seasonal allergy. 
Rhinitis is classified as allergic or nonallergic. The cause of nonallergic rhinitis is usually a 
viral infection, although irritants can cause it. The nose is the most commonly infected part of 
the upper airways. 
Allergic Rhinitis 
Allergic rhinitis is caused by a reaction of the body‘s immune system to an 
environmental trigger. The most common environmental triggers include dust, molds, 
pollens, grasses, trees, and animals. Both seasonal allergies and year-round allergies can 
cause allergic rhinitis. 
Symptoms of allergic rhinitis include itching, sneezing, runny nose, stuffiness, and itchy, 
watery eyes. People may have headaches and swollen eyelids and also may cough and 
wheeze. 
A doctor may diagnose allergic rhinitis based on a person‘s history of symptoms. Often, the 
person has a family history of allergies. More detailed information may be obtained from 
blood tests or skin testing. 
Nonallergic Rhinitis 
Non allergic Rhinitis is further classified in to acute viral rhinitis, chronic rhinitis, atrophic 
rhinitis, vasomotor rhinitis. 
Acute viral rhinitis 
Acute viral rhinitis can be caused by a variety of viruses, usually the common cold.Symptoms 
consist of runny nose, sneezing, congestion, postnasal drip, cough, and a low-grade fever. 
Stuffiness can be relieved by taking decongestants, such as oxymetazoline 
or phenylephrine as a nasal spray or pseudoephedrine by mouth. These drugs, available over 
the counter, cause the blood vessels of the nasal mucous membrane to narrow (constrict). 
Nasal sprays should be used for only 3 or 4 days because after that period of time when the 
effects of the drugs wear off, the mucous membrane often swells even more than before. This 
phenomenon is called rebound congestion. Antihistamines help control runny nose but cause 
drowsiness and other problems, especially in older people. Antibiotics are not effective for 
acute viral rhinitis. 
Chronic rhinitis 
Chronic rhinitis is usually an extension of rhinitis caused by inflammation or a viral infection. 
However, it also may rarely occur with diseases. These diseases include syphilis, 
tuberculosis, rhinoscleroma (a skin disease characterized by very hard, flattened tissues that 
first appear on the nose), rhinosporidiosis (an infection in the nose characterized by bleeding 
polyps), leishmaniasis, blastomycosis, histoplasmosis, and leprosy—all of which are 
characterized by the formation of inflamed lesions (granulomas) and the destruction of soft 
tissue, cartilage, and bone. Both low humidity and airborne irritants also can result in chronic 
rhinitis. 
Chronic rhinitis causes nasal obstruction and, in severe cases, crusting, frequent bleeding, and 
thick, foul-smelling, pus-filled discharge from the nose. 
Decongestants may relieve symptoms. Any underlying infection requires a culture 
(examination of microorganisms grown from a sample of mucus to identify infection with 
bacteria or fungi) or biopsy (removal of a tissue sample for identification under a microscope) 
and appropriate treatment. 
Atrophic rhinitis 
Atrophic rhinitis is a form of chronic rhinitis in which the mucous membrane thins 
(atrophies) and hardens, causing the nasal passages to widen (dilate) and dry out. This 
atrophy often occurs in older people. People who have granulomatosis with polyangiitis 
(formerly called Wegener granulomatosis) are also at risk. The cells normally found in the 
mucous membrane of the nose cells that secrete mucus and have hairlike projections to move 
dirt particles out are replaced by cells like those normally found in the skin. The disorder can 
develop in people who had a significant amount of intranasal structures and mucous 
membranes removed during sinus surgery. A prolonged bacterial infection of the lining of the 
nose is also a factor. 
Crusts form inside the nose, and an offensive odor develops. People may have recurring 
severe nosebleeds and can lose their sense of smell (anosmia). 
Treatment is aimed at reducing the crusting, eliminating the odor, and reducing infections. 
Antibiotics, such as bacitracin or mupirocin ointment applied inside the nose, kill bacteria. 
Estrogens sprayed into the nose or taken by mouth and vitamins A and D taken by mouth 
may reduce crusting by promoting mucosal secretions. 
Vasomotor rhinitis 
Vasomotor rhinitis is a form of chronic rhinitis. Nasal stuffiness, sneezing, and runny nose 
common allergic symptoms occur when allergies do not seem to be present. In some people, 
the nose reacts strongly to irritants (such as dust and pollen), perfumes, pollution, or spicy 
foods. The disorder comes and goes and is worsened by dry air. The swollen mucous 
membrane varies from bright red to purple. Sometimes, people also have slight inflammation 
of the sinuses. People do not have a pus-filled discharge or crusting. 
Treatment of vasomotor rhinitis is by trial and error and is not always satisfactory. If 
inflammation of the sinus is not severe, treatment is aimed at relieving symptoms. Avoiding 
smoke and irritants and using a humidified central heating system or vaporizer to increase 
humidity may be beneficial. Nasal corticosteroid and antihistamine sprays sometimes help. 
Nasal decongestant sprays should not be used. However, decongestants taken by mouth may 
be used for a few days at a time when symptoms are worst. 
Adenoid and Tonsil Hypertrophy 
Tonsil hypertrophy and adenoid hypertrophy occurs when the tonsils and the adenoids 
become swollen and chronically enlarged.  The condition can result in nasal obstruction 
leading to a number of symptoms and complications. Tonsil hypertrophy and adenoid 
hypertrophy are medical conditions that occasionally occur in adults but most commonly 
affect younger children. 
Both tonsils and adenoids are collections of lymphoid tissue that trap bacteria and viruses. 
They are part of the lymphatic system and help the body fight infections. The tonsils are 
located in the back of the throat and are visible through the mouth. The adenoids are located 
higher up and further back where the nasal passages connect with the throat. Unlike tonsils, 
adenoids are positioned behind the soft palate and cannot been seen through the mouth. The 
main function of the tonsils and adenoids is to prevent bacteria from reaching further down 
the throat by producing antibodies that bind to the bacteria. The adenoids and tonsils can 
progressively grow with ongoing infections and inflammation. 
Tonsil Hypertrophy 
Symptoms of Tonsil Hypertrophy 
Enlarged tonsils can be common in children, and in some cases, there are no apparent 
symptoms. However, when tonsil hypertrophy is more severe, children typically experience 
some of the following symptoms: 
 
 
  
 
 Voice changes: As a result of swollen tissue near the vocal chords, the voice may be 
altered slightly. 
 Difficulty swallowing: The enlarged tissue of the tonsils can become obstructive and 
make swallowing certain foods difficult. 
 Loss of appetite: When swallowing food is difficult or painful, many children eat less 
and lose their appetite. 
 Halitosis: Due to infections of the tonsils, bad breath often affects children with tonsil 
hypertrophy. 
 Snoring: Hypertrophic tonsils can obstruct the airways making breathing during sleep 
more difficult. 
 Obstructive sleep apnea: In severe cases of tonsil hypertrophy, sleep apnea, a condition 
indicated by pauses in breathing during sleep, can occur. This is due to blocked 
airways. Sleep apnea is a serious condition that can potentially cause pulmonary 
hypertension and hypertrophy of the right side of the heart. 
 Frequent ear infections: The enlarged tonsils can block the Eustachian tubes and 
impede drainage. This can result in fluid build up behind the eardrum and ear 
infections. 
 Chronic Sinusitis: Hypertrophic tonsils and surrounding tissue can prevent proper 
drainage from the sinus cavities. The mucous becomes trapped and infections can 
develop. Symptoms such as congestion, pressure and fatigue are common with 
sinusitis. 
Causes of Tonsil Hypertrophy 
The exact cause of tonsil hypertrophy is not always clear, but the enlargement is 
typically related to tonsillitis or infection of the tonsils and surrounding tissue. The bacteria 
trapped by the tonsils can sometimes lead to infections. It is possible that irritants such as 
second hand smoke and air pollution can also cause the tonsils to become enlarged. 
Treatments for Tonsil Hypertrophy 
Treatment for tonsil hypertrophy depends on the size of the tonsils and the severity of 
symptoms. Sometimes the enlarged tissue shrinks on its own or as the child grows, and no 
treatment is needed. If severe tonsil hypertrophy is not treated however, serious health 
conditions can result. Underlying infections can spread to other areas of the body, and 
untreated streptococcus bacteria (strep throat) can even damage the kidneys and heart valves. 
Both medication and surgery are used to treat tonsil hypertrophy. When infection is the cause 
of tonsil hypertrophy, antibiotics can be effective. Once the infection is cleared, the enlarged 
tonsil tissue typically returns to normal size. When the tonsils are chronically enlarged, 
surgery may be the best treatment option. The tonsils can be removed through a surgical 
procedure known as a tonsillectomy. 
 
 
Adenoid Hypertrophy 
Symptoms of Adenoid Hypertrophy 
The symptoms of adenoid hypertrophy can be similar to those of tonsil hypertrophy 
and occur when the enlarged adenoid tissue creates as an obstruction: 
 
 
 Mouth breathing: As a result of blocked nasal airways, children with adenoid 
hypertrophy are often forced to breath through their mouths. If mouth breathing occurs 
for a prolonged period of time, orthodontic issues can arise. 
 Runny nose: Because mucous cannot drain properly through the back of the nasal 
cavity, mucous and secretions exit through the nostrils. 
 Snoring and sleep apnea: The blocked airways caused by the enlarged adenoid tissue 
can interfere with breathing during sleep. 
 Chronic sinusitis: When enlarged adenoids block the nasal passages, the sinus cavities 
cannot drain properly. The buildup of mucous leads to inflammation of the lining and 
often infections. 
 Eustachian tube dysfunction: When enlarged adenoids prevent proper drainage from 
the Eustachian tubes, fluid collects behind the eardrum. 
Causes and Diagnosis of Adenoid Hypertrophy 
Like tonsil hypertrophy, the cause of adenoid hypertrophy is not completely clear. Bacteria, 
irritation from nasal secretions or chronic allergies can cause inflammation of the adenoid 
tissue.  This inflammation can lead to chronic adenoid hypertrophy. An ENT (Ear, Nose and 
Throat) specialist can diagnose hypertrophic adenoids by using x-ray or by performing a 
fiberoptic nasal exam.  With a fiberoptic nasal exam, a nasal spray is first used to numb the 
nasal passages. Then, inserting a flexible, fiberoptic tube through the nose, the ENT can view 
and examine the adenoids directly. 
Treatment of Adenoid Hypertrophy 
In some cases, medication can be used to treat adenoid hypertrophy. Infected adenoids 
may respond to antibiotics and adenoids may shrink with oral steroids. When medication 
does not correct the enlargement of the adenoid tissue, surgery is often needed. 
4. Pharyngitis 
Pharyngitis is caused by inflammation and swelling of pharyngeal mucosa. The main 
symptom of acute pharyngitis is a sore throat. Other symptoms may include fever, headache, 
joint pain and muscle aches, skin rashes, and swollen lymph nodes in the neck. Inspection 
discloses pharyngeal erythema, exudates, sometimes mucosal erosions and vesicles, tonsillar 
hypertrophy, anterior cervical lymphadenopathy, conjunctivitis, and skin rash. Similar to 
other upper respiratory infections, the most common cause of acute pharyngitis is viral 
infection. The most common pathogens are rhinovirus, and influenza A and B. Some other 
viruses can cause specific forms of pharyngitis, such as enteroviruses, Epstein-Barr virus 
(EBV), and HIV. 
Less commonly, pharyngitis is also caused by a bacterial infection. Acute bacterial 
pharyngitis and tonsillopharyngitis usually occur during the colder months. The most 
common cause is group A b-hemolytic Streptococcus (S. pyogenes), which is responsible for 
15–30% of all cases of pharyngitis in children and for 10% in adults. Antibiotic therapy is 
recommended to hasten the resolution of clinical symptoms, and to prevent the occurrence of 
nonsuppurative complications, such as rheumatic fever. A 10-day course of antibiotic therapy 
with penicillin is the standard of care for streptococcal tonsillopharyngitis.  
Symptoms of Pharyngitis 
Symptoms of pharyngitis may include the following: 
 Sore throat 
 Fever 
 Headache 
 Joint pain and muscle aches 
 Skin rashes 
 Swollen lymph glands in the neck 
Diagnosis of Pharyngitis 
A blood test might be done to determine whether an infection is more likely caused by a 
bacterial or viral agent. 
Treatment 
If sore throat is caused by a virus, antibiotics won't help and it will go away on its own 
within five to seven days.However, antibiotics can help if your sore throat is caused by 
bacteria.  
5. Laryngitis 
Laryngitis is an acute or chronic inflammation of laryngeal structures. It is an illness whereby 
the larynx becomes swollen and inflamed. It can be an acute (short-term) or chronic (long-
term) condition, although in most cases, the condition is temporary and has no serious 
consequences. 
The larynx, also referred to as the voice box, is the area of the throat that is home to the vocal 
cords- two small folds of mucous membrane covering cartilage and muscle that vibrate to 
produce sound. The larynx is used in the processes of breathing, swallowing, and talking. 
Laryngitis can be caused by: 
 Viral infections 
 Bacterial infections 
 Fungal infections 
Symptoms of laryngitis 
The most common symptoms of laryngitis include: 
 weakened voice 
 loss of voice 
 hoarse, dry throat 
 constant tickling or minor throat irritation 
 dry cough 
These symptoms are usually mild and can be treated water or other non-caffeinated fluids can 
help lubricate your throat. 
Tests and by giving your voice a break. Drinking  
Diagnosis 
Laryngitis is typically diagnosed through a physical examination that assesses the 
patient's ears, nose, throat, and voice. No additional testing is required for most diagnoses. 
The most common symptom of the condition is hoarseness, so doctors will take care 
to listen to the patient's voice. They may also ask questions about lifestyle, potential exposure 
to airborne irritants, and other related diseases. 
If a patient presents with chronic hoarseness, a doctor may recommend additional 
testing to fully examine the vocal cords. A laryngoscope can be used to observe the motion of 
the vocal cords when in use and to determine the presence of any polyps or nodules on the 
vocal cords. A biopsy can be carried out if a suspicious area of tissue requires further 
assessment. 
Anyone who has symptoms that last longer than 2 weeks should consult their 
physician. In some cases, a doctor may refer a patient to an otolaryngologist - an ear, nose, 
and throat (ENT) specialist. 
Treatments for laryngitis 
Cases of acute laryngitis are often best treated with rest, home, and self-care measures 
that can relieve symptoms. In this case, rest means limiting use of the larynx by reducing or 
refraining from talking, singing, or otherwise making noises that use the voice box. 
Whispering should also be avoided as this requires that the vocal cords are tightly stretched, 
hampering their recovery. 
Diagnostic Tests for Upper Respiratory Tract Infections 
 Complete blood count 
 Total count and differential count 
 Erythrocyte sedimentation rate 
 Absolute eosinophil count (AEC) 
 Radiograph of paranasal sinuses 
 Temperature 
 Gramstain for pathogens 
 IgE levels 
Diet 
 Fluid intake: Increased fluids are warranted to replace insensible losses and 
reduced oral intake. 
 Probiotics: Antibiotics alter the gastrointestinal flora, and some foods may not be 
as digestible for days or weeks after antibiotics are used. Consumption of yogurt 
containing active cultures has been advocated as an aid to restoring normal flora 
after antibiotic therapy. . 
Treatment 
 Anti tussive 
 Antibiotics 
 Anti-virals 
Prevention 
 Wash the hands frequently, especially after touching public surfaces like 
doorknobs and frequently wash toys, pacifiers, and other items that children tend 
to put in their mouths. 
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4. DRUG REVIEW 
rpWGs;sb vz;nza; SIRUPULLADI  ENNAI 
rpWGs;sbAk; fow;nfhOe;Jk; 
rpwe;jmThp rhzhf;fp 
eWnkd; nghLjiy xUgpbAk; 
iea eWf;fp ey;nyz;nza; 
epWKd; miuaha;f; fjpnuhd;Kd; 
NeNu itj;J ePaUe;j 
eWnkd; Foyha; Nky;g+r 
ehj dUshy; fze;jPUk;. – Foe;ij kUj;Jtk; (ghy thflk;) 
Ingredients of the Trial Drug 
1. Desmodium triflorum (Sirupulladi leaf)                
2. Caesalpinia bonduc (Kalarchi kolundhu)                
3. Indigofera tinctoria (Avuri leaf)                               
4. Ipomoea Marginata (Saanaki leaf)                           
5. Phyla nodiflora (Poduthalai leaf)                                
6. Sesamum indicum (Nallennai)                                    
1. rpWGs;sb ,iy (Desmodium triflorum) 
nra;if: 
ghw;ngUf;fp 
mfl;Ltha;tfw;wp, rpWePh;g;ngUf;fp, cukhf;fp 
nghJFzk;: 
khe;jfzk; Nghuhkk; td;ke;jk; ePq;fptpLk; 
Xa;e;jKiyg;ghYk; xOFq;fhz;- Nkhe;Nj 
rpWGs; sbJijahj; Njkyh;g;g+q; Nfhjha; ! 
rpWGs; sbiaepjQ; Nrh;;. 
-mfj;jpau; Fzthflk; 
nghUs;: 
khe;jk;, fzk;, fopr;ry; mlf;Fk;. ghiyr;Rug;gpf;Fk,; typiag; Nghf;Fk;. 
Scientific classification 
Binomial name :  Desmodium triflorum 
Kingdom  :  Plantae 
Order  :  Fabales 
Family  :   Fabaceae 
Genus  :  Desmodium 
Species  :  D. Triflorum 
Desmodium triflorum is a much branched, mat-forming, prostrate, annual to perennial herb, 
producing stems 8 - 50 cm long from a woody taproot. It behaves as perennial under 
conditions of well-distributed rainfall, and is an annual where the rainfall is seasonal. The 
stems are strongly branched and frequently root at the nodes. The plant is gathered from the 
wild for local medicinal use. The plant is antipyretic, antiseptic, expectorant. A decoction is 
commonly used to treat diarrhoea and dysentery; and to quench thirst. A decoction is used as 
a mouthwash; and the crushed plant, or a poultice of the leaves, is applied externally on 
wounds, ulcers, and for skin problems in general.The whole plant is used medicinally for 
inducing sweat and promoting digestion. 
Chemical constituents: 
Leaves contain β-phenylamine (major), indole-3-acetic acid, tyramine, trigonelline, 
hypaphorine, its methyl ester, N, N-dimethyl tryptophan methyl ester and S-l-stachydrine. 
Roots contain 3, 4-di-hydroxy phenylethyl trimethyl ammonium cation, choline and betaine. 
Root also contains an alkaloid hypaphorine. 
 
Medicinal uses: 
 Whole plant astringent, laxa tive, antipyretic, expectorant, antiseptic, used on skin 
rashes, wounds and abscesses and for inducing sweat and promoting  digestion; tender parts 
chewed to treat toothache; fresh juice  of the plant given to children for coughs; plant juice 
used as  ear drops to alleviate earache and also given as galactagogue;  of, mixed with  plant 
of Desmodiumtriflorum , leaves of Kadsurascandens  and fruits of Litseacubeba, drunk to 
treat measles, pox in  small children. Roots decoction for colic; root juice 
dropped  in  eye  to  treat  inflammation.   
Leaves  to  treat  diarrhea  and  dysentery, convulsions, wounds and abscesses fresh 
leaves  used  internally  as  a  galactagogue,  applied  to  wounds  and  abscesses;  young  leav
es  chewed  for  toothache;  a  paste  of  bruised leaves applied to itches, nails and indolent 
sores; leaf  juice applied for cuts, wounds and piles. Fresh leaves—used internally as 
galactagogue and for diarrhoea; applied externally to wounds and abscesses. Root—diuretic. 
Also used for cough, asthma.  
Article on anti-inflammatory activities of Desmodiumtriflorum: 
Desmodiumtriflorum is a plant belongs to the family Fabaceae. It is a global species native to 
tropical regions and introduced to subtropical regions including the southern United States. 
The plant is having antipyretic, antiseptic, expectorant properties. A decoction is commonly 
used to treat diarrhoea and dysentery; quench thirst; and as mouthwash. The crushed plant, or 
a poultice of the leaves, is applied externally on wounds, ulcers, and for skin problems. In 
general the whole plant is used medicinally for inducing sweat and promoting digestion, anti-
oxidant, anti-inflammatory, anti-convulsant and anti-bacterial actions. This review explains 
the different pharmacological activities of Desmodiumtriflorum. 
 
2. fow;rp nfhOe;J (Caesalpinia bonduc) 
nra;if: 
tPf;fKUf;fp 
UJTz;lhf;fp 
nghJFzk;: 
tpiuthjQ; #iyaWk; ntl;ilad NyFk; 
epiuNrh;e;j Fd;kk; epiyah- JiuNrh; 
mow;rp tpyFk; mUe;jp;w; frg;ghq; 
fow;rpapiy nad;Wiuf;Fq; fhy;. 
-mfj;jpau; Fzthflk; 
nghUs;: fUq;fow;rp ,iyahy;, mz;lthA, #iyf;fl;L, nts;is, gytpj Fd;kk,; 
cs;soiy Mfpait xopAk;. 
nghJFzk;: 
Vwz;lj; NjhNl apwq;fz;l nkj;jTNk 
tPwz;l nky;yhk; tpyf;Fq;fhz;- J}uz;l 
ts;isf; FioabNghk; ths;tpopkhNj ! ey;y 
nts;isf;- fow;rpapiy tps;. 
-mfj;jpau; Fzthflk; 
nghUs;: 
ntz;fow;rp ,iyahy,; Vwz;lk,; ,wq;fz;lk,; jiraz;lk; ,it Nghk; 
Scientific classification 
Binomial name : Caesalpinia bonduc 
Kingdom  :  Plantae 
Family  :  Caesalpiniaceae 
Genus  :  Caesalpinia 
Species  :  C. Bonduc 
Caesalpinia bonduc, commonly known as Grey Nicker, is a species of flowering plant in 
the senna family, Caesalpiniaceae,
 
that has a pantropical distribution. It is a liana that reaches 
a length of 6 m (20 ft) and scrambles over other vegetation. Stems are covered in curved 
spines.  Its 2 cm (0.79 in) grey seeds known as nickernuts, are buoyant and durable enough to 
be dispersed by ocean currents.  
Phytochemicals : 
                       Whole plant of Caesalpinia bonducella contain all major chemical 
constituents such as Steroidal Saponin, Fatty Acids, Hydrocarbons, Phytosterols, Isoflavones, 
Aminoacids, and Phenolics. 
 
Traditional and Modern Uses : 
The seed is claimed to be styptic, purgative and anthelmintic and cures inflammations, useful 
in colic, malaria, hydrocele, skin diseases and leprosy.  The ointment is made from the 
powdered seeds with castor oil and applied externally in hydrocele and orchitis . The seeds 
are considered tonic, ferifuge, anthelmintic, antiblennorrhagic, and specific in the treatment 
of hydrocele. The oil from the seeds is used in convulsions and paralysis. In Guinea, the 
pounded seeds are considered vesicant. The powdered seeds were mixed with equal part of 
pepper powder to malaria patients and were found to posses feeble antiperiodic properties. In 
malignant malaria, they did not do any good. The seeds are ground in water and given 
internally in snake-bite. The seeds are not an antidote to snake-venom. Seed and long pepper 
powders taken with honey gives good expectorant effect. Burnt seeds with alum and burnt 
arecanut are a good dentifrice useful in spongy gums, gum boils, etc. In West Indies, the 
roasted seeds are used as anti diabetic.  
The kernel of the seed is very useful and valuable in all ordinary cases of simple, continued 
and intermittent fevers. The kernel powder mixed with equal parts of black pepper is taken 
thrice a day in a dose of 15-30 grains by adults and 3-4 grains by children. the roots are 
considered febrifuge and anthelmintic, they are much used as an astringent in leucorrhoea and 
blennorrhagia. In Guinea, a decoction of the root is prescribed in fever. The root-bark is good 
for tumours and for removing the placenta after child birth. Bark of root possesses number of 
properties like febrifuge, intestinalworms, amenorrhoea, cough, and anthelmintic etc. In 
Jamaica, it is used as rubifacient and as a local application for sores.  Flowers are used in 
treating ascites and fruits in treating urinary disorder, leucorrhoea, piles and wounds.    
Leaves and twigs are traditionally used for the treatment of tumors, inflammation and liver 
disorder. They have also been applied for treatment of toothache. Leaves and juices have 
been used traditionally for elephantiasis and smallpox.  
Pharmacological Activities:  
Antiinflammatoryactivity, Antimalarial activity 
Antibacterial, Antifungal, 
Antimicrobial activity 
Antidiarrhoeal activity 
Antioxidant activity, Antiproliferative activity 
Article on Antibacterial, antidiarrhoeal, activities of Caesalpiniabonducella  
Caesalpiniabonducella is an important medicinal plant for its traditional uses against 
different types of diseases. Therefore, the present study investigated the antimicrobial, 
antidiarrhoeal, and cytotoxic activities of the methanol extract and ethyl acetate, chloroform, 
and petroleum ether (pet. ether) fractions of C. bonducella leaves 
3. mThp ,iy(Indigofera tinctoria) 
nra;if: 
El;GOf;nfhy;yp 
Kiwntg;gfw;wp 
ntg;gKz;lhf;fp 
nghJFzk;: 
chpayT hpj;jioj;jhd; xJ gjpndz; 
mhpaeQ;irj; jpd;wth;f;Fk; MFk;- njhpthpa 
thjntg;G fhkhiy ike;jh; FWkhe;jQ; 
rPjk; mfw;We; njhp. 
-mfj;jpau; Fzthflk; 
 
rd;dp gjp%d;WQ; re;njhbj;j thjKjy; 
cd;D tplf;fbAk; xLq;fhz;-kpd;Dq; 
fThpepwk; cz;lhFq; fhrpdpAs; ey;y 
mThpapiy jd;dhy; mwp. 
-mfj;jpau; Fzthflk; 
nghUs;: 
,J gjpndz;tif eQ;Rfisg; Nghf;Fk;. tspRuk;, fhkhiy, khe;jk; , rPjsk; , 
Kg;gpzp, fPy;thjk; ,itfisg; Nghf;Fk;. cly; nghd; epwk; ngWk; 
Scientific classification 
Binomial name : Indigofera tinctoria 
Kingdom  :  Plantae 
Family  :  Fabaceae 
 Genus  :  Indigofera 
Species  :  I. tinctoria 
Indigofera tinctoria, also called true indigo, is a species of plant from the bean family that 
was one of the original sources of indigo dye. It has been naturalized to tropical and 
temperate Asia, as well as parts of Africa, but its native habitat is unknown since it has been 
in cultivation worldwide for many centuries. Today most dye is synthetic, but natural 
dye from I. tinctoria is still available, marketed as natural coloring where it is known as 
tarum in Indonesia and nila in Malaysia. In Iran and areas of the former Soviet Union it is 
known as basma. The plant is also widely grown as a soil-improving groundcover. True 
indigo is a shrub one to two meters high. It may be an annual, biennial, or perennial, 
depending on the climate in which it is grown. It has light green pinnate leaves and sheafs of 
pink or violet flowers. 
Chemical constituents: 
A galactomannan from seed; Apigenin, Indigotin, Kaempferol, Tutetion, rotenoids degueli 
dehydrodeguelin, rotenol, rotenone, tephrosin and sumatrol from various parts of plant- auri 
Medicinal uses: 
The plant also contains rotenoids which are effective insecticides against mosquito 
larvae.  Because of its use in traditional medicine there have been studies to attempt to 
support these uses. Indigotin, the substance responsible for the blue of the dye is thought to 
have antiseptic and astringent properties, and there are studies currently underway on 
indirubin, also found in woad, to discover if it has anti-cancer properties. Early studies have 
shown that the alcohol extracts of indigo‘s stems and leaves protect the liver from damage by 
chemicals such as carbon tetrachloride, found in cleaningplant‘s extracts from the leaves have 
potent antioxidant actions and antibacterial and anti-cancer ones. However the studies were 
carried out on animals and in vitro, no tests have been done on human subjects in any of the 
research quoted here. 
 In the same study the leaves were analyzed and found to contain flavonoids, saponins, 
tannins, steroidal terpenes, phenols and anthroquinone, and were found to be effective against 
lung cancer cells in vitro. The report concludes with this sentence ―This study suggests that 
ethanol extract (sic) of Indigoferatinctoria have profound antibacterial, antioxidant and 
cytotoxic effect. In another study, ―Anti-hyperglycaemic activity of ethanol extract and 
chloroform extract of Indigoferatinctoria leaves in streptozotocin induced diabetic mice 
(Family Papilionaceae)‖ Indigoferatinctoria leaves alcoholic extract long-term treatment may 
be beneficial in the management of type-1, type-2 diabetes.‖   
In traditional Chinese medicine indigo has been used as a pain reliever, for fever, 
inflammation and to purify the liver and blood. In Indian traditional medicine it has been used 
to promote hair growth and is used as a hair dye for black hair, just as henna is used for red 
hair. It has been used for centuries in Ayurveda to treat depression, for cancer, bronchitis and 
other respiratory problems such as asthma, hemorrhaging, as well as problems with the 
spleen, lungs and kidneys. Some research suggests that it has liver protective properties. In 
other traditional medicine systems in the Indian subcontinent it has also been used for cardio-
vascular problems, urinary tract problems and the paste made with the leaves is applied to 
sores, ulcers and piles and a decoction of the leaves was applied to the stings and bites of 
venomous creatures as well as to relieve pain and aid fast healing of burns and scalds.   
Article of Immunomodulatory activity of indigofera tinctoria leaf :  
In this study the effects of ethanolic and aqueous extracts of Indigoferatinctoria were 
investigated on the functions of peritoneal macrophages and peripheral blood lymphocytes 
isolated from Wistar rats through in vitro studies.   Macrophage functions were determined 
through Nitric oxide (NO) estimation, Arginase production, lysosomal, phagocytic activities 
and analysis of proinflammatory cytokines (TNF-αand IL-1β) production. The lymphocytes 
proliferation was analyzed by MTT assay. 
The results indicated that both ethanolic and aqueous extracts of I. tinctoria were enhanced 
nitric oxide (NO) production at 50µg/ml whereas it suppressed the production of arginase at 
100 µg/ml by the macrophage. Moreover lysosomal and phagocytic activity of the 
macrophage was enhanced by the ethanolic and aqueous extracts at a dose of 100µg/ml. The 
extracts also enhanced the production of pro-inflammatory cytokines by the macrophages. 
With the lymphocytes.  Collectively the results demonstrated that both extracts of I. tinctoria 
enhanced innate as well as adaptive immune response and proved the immunostimulating 
potential of the plant I. tinctoria. 
 
4. rhzhf;fpf; fPiu (Ipomoea Marginata) 
nra;if: 
Nfhioafw;wp El;GOf;nfhy;yp rpWePh;g;ngUf;fp 
nghJFzk;: 
NfhioNahL khe;jq; Foe;ijr; fopf;fzKk; 
Ngionadr; nrhy;Yk; ngUtapWk;- fPnohUth; 
fhzhf; fpUkpfisf; ff;F kopGz;Z}Q;  
rhzhf;fpf; fPiuapw;NghQ; rhw;W. 
-mfj;jpau; Fzthflk; 
nghUs;: 
 ,jdhy; fgk; , grpj;jP ke;jk,; Ropf;fzk; , ngUtapW, GO nespfpd;w Gz; 
Mfpa ,it Nghk;. 
Scientific classification 
Binomial name : Ipomoea Marginata  
Kingdom  :  Plantae 
Family  :  Convolvulaceae   
Genus  :  Ipomoea 
Species  :  I. Marginata  
Ipomoea marginata is a species of Phanerogama belonging to the family Convolvulaceae. It 
is one of the Ten Sacred Flowers of Kerala. It has alternating leaves, triangular-cordiformes, 
5-8 by 3-5 cm, base cordate, apex acuminate, faintly pubescent, petiole 1-2 cm long.The 
inflorescences on sub-humid peaks. The calyx lobes are equal, obovate, globrous. 3cm pink-
white corolla. The fruit is a globose capsule; with pubescent seeds. 
Chemical constituents: 
All leaves contain phenolics, flavonoid, hydroxyanthraquinones and Saponins . Humans use 
Ipomoea for their content of medical and psychoactive compounds, mainly alkaloids. Some 
species are renowned for their properties in folk medicine and herbalism; for example Vera. 
Article on antibacterial activity  of Ipomoea marginata: 
 Ipomoea marginata is one of the valuable medicinaplants having many therapeutic uses.the 
human pathogens selected for the study was staphylococcus,shigella sonnei,Entrrobacteria 
faecalis. Preliminary phytochemicals in the different extracts of  Ipomoea marginata for the 
detection of alkaloids,carbohydrates,flavonoids,phenolic compounds,tannins,protein which 
can act as a potent anti bacterial agent. 
5. nghLjiy ,iy(Phyla nodiflora) 
nra;if: 
cs;soyhw;wp  tPf;fq; fiur;rp 
rpWePh;g;ngUf;fp  Jth;g;gp 
Nfhioafw;wp cukhf;fp 
nghJFzk;: 
nghLjiyapd; NgUiuj;jhy; Nghuhkg; Nghf;Fk; 
mLjiynra; fhrk; mlq;Fk;- fLfptU 
NgjpnahL #iyNea; ngrhpa ntz;Nkfk; 
thjKk;Ngh nka;Auf;Fk; tho;j;J. 
-mfj;jpau; Fzthflk; 
nghUs;: 
,jdhy; rPjf;fopr;ry,; ngUq;fopr;ry;, ,Uky,; #iyNeha;, nts;is, tsp Neha; ,it 
Nghk;. cly; td;ikg;gLk;. 
Scientific classification 
Binomial name : Phyla nodiflora 
Kingdom  :  Plantae 
Family  :  Verbenaceae 
Genus  :  Phyla 
Species  :  P. nodiflora 
 Phyla nodiflora (frog fruit, sawtooth fogfruit, turkey tangle), is an ornamental plant in 
the Verbenaceae family, and is native to South America and the United States. It can be 
found in tropical areas around the globe, a naturalized species in many places. This plant is 
cited in Flora Brasiliensis by Carl Friedrich Philipp von Martius. It is often grown 
ornamentally as a ground cover plant, and is often present in yards or disturbed areas as a 
lawn weed. The inflorescence consists of a purple centre encircled by small white-to-
pink flowers. The flower takes on a match-like look, which is why the plant is sometimes 
called matchweed. It is similar to the related species Phyla lanceolata, but differs in having 
much shorter leaves that are often blunt and much more rounded. Both species are common 
as weeds and in the ornamental environment 
Chemical constituents: 
                                The plant contains a variety of constituents such as triterpenoids, 
flavonoids, phenols, steroids and many others. Amoung these flavonoids were the most 
commonly found. Nodifloretin B-sitisterol glycoside and stigmasterol glycoside from the 
leaves of L.nodiflora Nodifloridin along with lactose, maltose, fructose, and xylose were 
isolated from the plant. Two new flavone ghycosides lippiflorin along with the known 
compound nepetin and batalifilin from the ethanol extract of L.nodiflora were isolated. From 
the flowers of L.nodoflora, two flavones glycosides, hydroxyluteolin Oapioside and luteolin, 
glucoside, and three flavones, hydroxyluteolin, nepetin, and batatifolin were isolated . From 
the alcoholic extracts of L.nodiflora, two phenypropanoid compounds acteoside and O-
acetylechinacoside and a flavone demethoxycentaureidin were isolated. From L.nodiflora, 
tweleve flavones sulfates Hispidulin sulfate, Hispidulin, disculfate, Jaceosidin, disulfate, 
Nepetin, disulfate, Nodifloretin, disulfate, Hydroxyluteolin, Nodifloretin, sulfate 
Hydroxyluteolin sulfate, Hydroxyluteolin, sulfate, Jaceosidin, sulfate, Nepetin, sulfate, and 
Hispidulin sulfate along with the known compounds Nepetin, Hispidulin, and Jaceosidin. 
Halleridone and Hallerone as their acetyl dervatives from the leaves of L.nodiflora were 
isolated. From the methanolic extract of the aerial parts of L.nodiflora, a new triterpenoid 
lippiacin, a new steroid 4‘, 5‘ dimethoxybenzoloxy stigmasterol along with the known 
stigmasterol and B-sitosterol were isolated. 
The plant was fractionated several constituents from the phyla nodoflora using multi 
component solvent systems; Hexane : Toluene:Ethyl acetate  for methanol extract and 
Hexane : Ethyl acetate  for chloroform and petroleum ethere extract. Five different phenolic 
components were isolated and were compared using  HPTLC, among these extracts, the 
highest number of constituents were isolated from the butanol extract. The molecular basis of 
a compound, cyclo pentane phenanthrenol, which exhibit anti inflammatory property was 
also given. Nodofloretin, a new flavone was also discovered . Chemical and biological 
investigations of medicinal herbs phyla nodiflora was done. Steroidal constituent from the 
aerial parts of Lippia nodiflora Linn was also obtained.  
Medicinal uses: 
1. It has wonderful anti bacterial properties making it very effective for treating all kinds 
of wounds when applied as a poultice.
 
2. It has anti inflammatory properties making it very effective as a home remedy for 
treating knee and joint pain. It also reduces piles inflammation when taken internally.  
3. It has anti diabetic properties making it a very effective natural remedy for reducing 
blood sugar levels for diabetic patients. 
4. It also has diuretic properties and people who are suffering from water retention will 
benefit drinking a water decoction of the plant. 
5. It also has anti urolithiatoc properties (prevention of formation of kidney stones). It 
not only prevents, it also effectively treats existing stones. 
6. Phyla nodiflora has anti proliferative properties and especially the stem and the leaf 
extract inhibits breast cancer cell growth. 
7. It also has anti fungal properties making it very effective for treating fungal infections 
when applied topically as a poultice. 
Artical on Antibacterial activity, Antimicrobial activity& Anti-inflammatory activity 
 of Phyla nodiflora: 
This study describes the extraction, fractionation and antibacterial activity of Phyla nodiflora. 
The plant crude extract and all sub fractions (n-hexane, chloroform, ethyl acetate, n-butanol 
and aqueous) were subjected to antibacterial activities. For antibacterial activities seven 
bacterial strains Escherichia coli, Pseudomonas aeruginosa, Klebsiellapneumoniae, 
Salmonella typhi, Staphylococcus epidermidis, Staphylococcusaureus (MRSA) and Bacillus 
subtillus were used in antibacterial assay. Ethyl acetate and chloroform fractions showed 
excellent activity against Bacillus subtilis, Staphylococcus epidermidis and Staphylococcus 
aureus. Phyla nodiflora is used in colic, asthma, diarrhea, bronchitis, ulcers, gonorrhea fever, 
knee joint pain, anti-inflammatory and antiplasmodic. The phytochemical study of plant 
shows that it contain flavonoids, sugar, essential oil, sterols, resins, tannins and non 
glucosides  bitter substances .  
In the present study we have chosen the plant Phyla nodiflora used in herbal medicine to 
determine its antibacterial property.This plant against some gram positive and gram negative 
pathogenic microorganism 
Antimicrobial activity: 
The Methanolic extract of Phyla nodiflora had been evaluated for antibacterial. The anti 
microbial screening was performed by agar diffusion method using a paper disc. The ethanol 
extract showed significant antibacterial activity due to the presence of bio-active compounds 
when compared with petroleum ether and aqueous extract. 
Anti-inflammatory activity: 
The crude methonal extract and the isolated compound of cyclo-pentanophenanthrenol from 
L.nodaflora were assessed for anti-inflammatory activity. Thus the compound was concluded 
to exhibit anti inflammatory activity 
6. ey;nyz;nza; (Sesamum indicum) 
nra;if: 
cs;soyhw;wp 
kykpsf;fp 
clYukhf;fp 
twl;rpafw;wp 
nghJFzk;: 
Gj;jpeadf;Fsph;r;rp g+hpg;G nka;g;GsfQ; 
Rj;Jtq; fj;jp jdpapsik- nkj;jTz;lhq; 
fz;Nzha; nrtpNeha; fghytoy; fhrneha; 
Gz;Nzha;Ngh nkz;nza;ahw; Nghw;W. 
-mfj;jpau; Fzthflk; 
 
 
 
nghUs;: 
,J Gj;jpf;Fj; njspT,; tpopfSf;Ff; Fsph;r;rp,; cly; g+hpg;G,; cly; td;ik 
Mfpatw;iwj; jUtNjhL fz;Nzha; , nrtpNeha,; jiy nfhjpg;G,; nrhwp rpuq;F,; Gz; 
KjypaitisAk; Nghf;Fk;. ,Ukiyj; jzpf;Fk;. kdkfpo;r;rpiaj; jUk; 
 Kingdm: Plantae  (Angiosperms) 
 Order: Lamiales 
 Family: Pedaliaceae 
 Genus: Sesamum 
 Species: S. indicum 
       Sesamum Indicum (Sesame) Seed Oil is a pale yellow oil made from sesame seeds. 
Sesame is an annual plant growing 50 to 100 cm (1.6 to 3.3 ft) tall, with opposite leaves 4 to 
14 cm (1.6 to 5.5 in) long with an entire margin; they are broad lanceolate, to 5 cm (2 in) 
broad, at the base of the plant, narrowing to just 1 cm (0.4 in) broad on the flowering stem. 
The flowers are yellow, tubular, 3 to 5 cm (1.2 to 2.0 in) long, with a four-lobed mouth. The 
flowers may vary in colour, with some beiSesame seeds are small. Their size, form, and 
colours vary with the thousands of varieties now known. Typically, the seeds are about 3 to 
4 mm long by 2 mm wide and 1 mm thick. The seeds are ovate, slightly flattened, and 
somewhat thinner at the eye of the seed (hilum) than at the opposite end. 
Chemical composition: 
Sesame seeds contain the lignanssesamolin, sesamin, pinoresinol and lariciresinol. 
Medicinal uses:  
 Prevents respiratory disorders 
 A good source of protein 
 Prevents diabetes: 
 Natural cure for anemia: 
 Innate anti-cancerous properties 
 Prevents cardiovascular & rheumatoid arthritis symptoms 
 Good digestive health  
 The weight of the seeds is between 20 Nutritional information: 
 In a 100-gram amount, dried whole sesame seeds provide 573 calories and are composed of 
5% water, 23% carbohydrates (including 12% dietary fiber), 50% fat, and 18% protein In a 
100-gram amount, dried whole sesame seeds provide 573 calories and are composed of 5% 
water, 23% carbohydrates (including 12% dietary fiber), 50% fat, and 18% protein . Whole 
sesame seeds are rich (20% or more of the Daily Value, DV) in several B vitamins and 
dietary minerals, especially iron, magnesium, calcium, phosphorus, and zinc.  The by-product 
that remains after oil extraction from sesame seeds, also called sesame oil meal, is rich in 
protein (35-50%) and is used as feed for poultry and livestock.  
 Sesame Seeds Benefits for 1. Natural anti-inflammatory agents: 
 Sesame seed oil has anti-inflammatory properties which makes it an innate healing agent. 
The antibacterial properties help in fighting various bacteria, including staphylococcus, 
streptococcus, and athlete‘s foot fungus, affecting the skin. A mixture of sesame seed oil and 
lukewarm water is an effective home remedy for vaginal yeast infections. 
Antibacterial activity: 
Antibacterial activity of silver nanoparticles produced by Sesamum indicum seed extract 
on staphylococcus epidermidis and salmonella typhi. 
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5. MATERIALS AND METHODS 
5.1. Preparation of the Trial drug SIRUPULLADI ENNAI 
Ingredients: 
                     Sirupulladi [Desmodium gangeticum ] rpWGs;sb ,iy    -1gpb                             
                     Kalarchi kolundhu[Caesalpinia bonduc ]    fow;rp nfhOe;J -1gpb  
                  Avuri leaf  [Indigofera tinctoria]   mTup ,iy           -1gpb                           
                     Saanaki leaf [Ipomoea marginata]   rhzhf;fpapiy       -1gpb                                              
                     Poduthalai leaf  [Phylla nodiflora ]  nghLjiy ,iy          -1gpb                                              
                     Nallennai [Gingelly oil]  ey;nyz;nza;                                 -650ml 
Method of purification: 
Sirupulladi leaf:  Remove the veins and wash in pure water .  
Kalarchi kolundhu:  Remove the veins and wash in pure water. 
 Avuri leaf:    Remove the veins and wash in pure water. 
Saanaki leaf:   Remove the veins and wash in pure water.  
Poduthalai leaf :   Remove the veins and wash in pure water. 
 Nallennai:   Keep the oil with clean water one  hour thirty minutes. 
 
                                       
        
rpWGs;sb ,iy                            fow;rp nfhOe;J                 
   
 
 
       
mTup ,iy    rhzhf;fpapiy   
 
    
nghLjiy ,iy      ey;nyz;nza; 
Method of Preparation:  
Take handful of each first 5 ingredients mentioned above and purify them accordingly. 
Disintegrate each ingredient & mix them with 650ml of gingelly oil taken in a mud pot. 
Cover the mouth of the mud pot with thin clean white cloth & expose the pot to the direct sun 
light. Preserve the medicine in a clean air tight container. 
 
Prepared Trial Drug –Sirupulladi Ennai 
 
 
5.2 Preclinical Studies: 
5.2.1 In-vitro Anti-Inflammatory Activity by Protein (Albumin) denaturation Assay: 
Albumin Denaturation Assay Procedure: 
In-vitro anti-inflammatory activity Sirupuladi Oil (SPO) was studied using albumin 
denaturation technique. The reaction mixture consisted of bovine serum albumin (5% 
aqueous solution) and test sample SPO at varying concentration ranges from 100 to 500 
mcg/ml and standard diclofenac sodium at the concentration of100 mcg/ml of final volume. 
pH was adjusted by using a small amount of 1N Hydrochloric acid. The samples were 
incubated at 37°C for 20 min and then heated at 57°C for 3 min. After cooling the sample, 2.5 
ml of phosphate buffer solution was added into each test tube. Turbidity developed was 
measured spectrophoto-metrically at 660 nm, for control distilled water was used instead of 
test sample while product control tests lacked bovine serum albumin. The experiment was 
performed in triplicate. 
The Percentage protection from denaturation is calculated by using the formulae 
 
Statistical analysis 
Results are expressed as Mean ± SD. The difference between experimental groups was 
compared by One-Way Analysis Of Variance (ANOVA) followed by Dunnet Multiple 
comparison test 
 
Preparation of Test and control 
 
 
Absorbance of reaction mixture – Test Sample 
 
 
Absorbance of reaction mixture – Control and Standard 
 
 
5.2.2. Physicochemical Analysis 
Percentage Loss on Drying 
10gm of test drug (weight equivalent to oil) was accurately weighed in evaporating dish .The 
sample was dried at 105
o
C for 5 hours and then weighed. 
Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 100 
Determination of Total Ash 
3 g of test drug (weight equivalent to oil) was accurately weighed in silica dish and 
incinerated at the furnace a temperature 400 ºC until it turns white in color which indicates 
absence of carbon. Percentage of total ash will be calculated with reference to the weight of 
air-dried drug. 
Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of pH 
Sample being oily in nature the direct litmus evaluation method was adopted to check the pH 
of the sample.  
Determination of Iodine value  
About 20 gm of oil was transferred into Iodine flask. To which 10 ml of chloroform was 
added and warmed slightly and cooled for 10 minutes. Followed by this about 25 ml of Wiji‘s 
solution was added in the same flask and shaken well. The flask was allowed to stand for 30 
mins and refrigerated for an hour. About 10 ml of KI solution was added to this and titrated 
against 0.1 N Sodium thiosulphate solutions until the appearance of yellow colour. 1 ml of 
starch indicator was added and again titrated against the sodium thiosulphate solution from 
the burette. Disappearance of blue colour indicates end point. Repeat the above procedure 
without taking sample and note the corresponding reading for blank titration. 
Determination of saponification value  
About 2 gm(weight equivalent to oil) of test sample was transferred into the round bottomed 
flask. To this about 20 ml of 0.5 N alcoholic KOH solutions was added to the round bottomed 
flask. Repeatthe same procedure with out taking the sample for blank titration . Reflux both 
sample and blank round bottomed flasks for 1 hour. After reflux, allow both the round 
bottomed flasks to cool. Titrate the samples using 0.5 N HCl with phenolphthalein indicator. 
The disappearance of pink indicates the end point.  
5.2.3 Phyto Chemical Analysis 
Sample Preparation 
Sirupuladi Oil  (SPO) was extracted with hexane and the extract was subjected to the 
following analysis 
Test for Alkaloid- Mayer's reagent 
To the test drug about 2ml of Mayer's reagent was added and was observed for the presence 
of alkaloids. Appearance of dull white precipitate indicates the presence of alkaloids. 
Test for flavonoid 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were been added followed 
by addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates the 
presence of Flavonoids. 
Test for Glycosides -Borntrager‟s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water bath, 
filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated and 
10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
Test for Triterepnoids 
To the test solution 2ml chloroform was added with few drops of conc. Sulphuric acid (3ml) 
at the side of the test tube. An interface with a reddish brown coloration is formed if 
terpenoids constituent is present. 
Test for Steroids - Salkowski test 
To the test solution 2ml of chloroform was added with few drops of conc. Sulphuric acid 
(3ml), and shaken well. The upper layer in the test tube was turns into red and sulphuric acid 
layer showed yellow with green fluorescence. It showed the presence of steroids. 
Test for Carbohydrates - Benedict‟s test 
To 0.5 ml of test drug about 0.5 ml of Benedic‘s reagent is added. The mixture is heated on a 
boiling water bath for 2 minutes. A characteristic coloured precipitate indicates the presence 
of sugar. 
Test – Phenol- Lead acetate test 
The test sample is dissolved in of distilled water and to this 3 ml of 10% lead acetate solution 
is added. A bulky white precipitate indicates the presence of phenolic compounds. 
Test for tannins  
About 0.5ml of test sample is boiled in 20 mL of distilled water in a test tube and then filtered. The 
filtration method used here is the normal method, which includes a conical flask and filter paper. The 
0.1% FeCl3 is added to the filtered samples and observed for brownish green or a blue black 
coloration, which shows the presence of tannins 
Test for Saponins 
The test drugs were shaken with water vigorously for 10 mins , copious lather formation 
indicates the presence of saponins. 
Test for Proteins (Biuret Test) 
Biuret test: Equal volume of 5% solution of sodium hydroxide and 1% copper sulphate were 
added. Appearance of pink or purple colour indicates the presence of proteins and free amino 
acids. 
 
 
Test of Coumarins 
1 ml of extract, 1 ml of 10% sodium hydroxide was added. The presence of coumarins is 
indicated by the formation of yellow color. 
Test for Anthocyanin 
About 0.2 ml of the extract was weighed in separate test tube, 1ml of 2N Sodium hydroxide 
was added, and heated for 5 minutes at 100 ± 2°C. Observed for the formation of bluish green 
color which indicates the presence of anthocyanin. 
5.3 Biochemical analysis: 
Biochemical Analysis of Sirupilladi Ennai was done at the Biochemistry lab at National 
Institute of Siddha, Chennai by the method of Kolkate. 
Preparation of Extract: 5ml of sample was taken in a 250ml clean beaker and added with 
50ml of distilled water. Then it is boiled well for about 10 minutes. Then it is cooled and 
filtered in a 100ml volumetric flask and made up to 100ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/basic radicals and biochemical 
constituents in it. 
Test for Silicate 
A 2ml of the sample was shaken well with distilled water. 
Action of Heat 
  A 2ml of the sample was taken in a dry test tube and heated gently at first and then strong. 
Action of Heat 
A 2ml of the sample was taken in a dry test tube and heated gently at first and then strong. 
Ash Test 
A filter paper was soaked into a mixture of extract and dil. cobalt nitrate solution and 
introduced into the Bunsen flame and ignited 
I. Test for Acid Radicals 
Test for Sulphate: 
2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% dil 
ammonium oxalate solution 
Test for chloride: 
2ml of the above prepared extracts was added with 2ml of dil.HCl is added until the 
effervescence ceases off. 
Test for Phosphate: 
2ml of the extract were treated with 2ml of dil.ammonium molybdate solution and 2ml of 
con.HNo3. 
Test for carbonate: 
 2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
Test for Nitrate: 
1gm of the extract was heated with copper turning and concentrated H2So4 and viewed the 
test tube vertically down. 
II.Test for Basic radicals 
Test for lead: 
2ml of the extract was added with 2ml of dil.potassium iodine solution. 
Test for copper: 
One pinch (25mg) of extract was made into paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the flame. 
Test for Aluminium: 
To the 2ml of extract dil.sodium hydroxide was added in 5 drops to excess. 
Test for Iron:  
           a. To the 2ml of extract add 2ml of dil.ammonium solution  
           b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is adde. 
Test for Zinc: 
To 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess and 
dil.ammonium chloride is added.  
Test for Calcium: 
 To 2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution 
Test for Magnesium: 
To 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
Test for Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and excess of dil.sodium hydroxide solution are 
added. 
Test for Potassium: 
A pinch (25mg) of extract was treated of with 2ml of dil.sodium nitrite solution and then 
treated with 2ml of dil.cobalt nitrate in 30% dil.glacial acetic acid. 
Test for Sodium: 
2 pinches (50mg) of the extract is made into paste by using HCl  and introduced into the blue 
flame of Bunsen burner. 
Test for Mercury: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution. 
Test for Arsenic: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution 
 
III. Miscellaneous 
Test for Starch: 
2ml of extract was treated with weak dil.Iodine solution. 
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The colour 
changes are noted. 
Test for the Alkaloids: 
      a) 2ml of the extract was treated with 2ml of dil.potassium Iodide solution. 
      b) 2ml of the extract was treated with 2ml of dil.picric acid. 
     c) 2ml of the extract was treated with 2ml of dil.phosphotungstic acid. 
Test for Tannic Acid: 
 2ml of extract was treated with 2ml of dil.ferric chloride solution. 
Test for Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium permanganate solution is added. 
Test for Type of Compound: 
2ml of the extract was treated with 2 ml of dil.ferric chloride solution. 
5.4 Clinical Studies 
40 Children with confirmed diagnosis of NEER KANAMANTHAM with satisfying the 
inclusion criteria were enrolled after obtaining written informed consent and were to receive 
SIRUPULLADI ENNAI with dosage of 1.6 ml BID for 3dayss 
Study design and conduct of study:  
 Study type:  An open clinical study  
  Study place:   OPD and IPD of Ayothidas Pandithar Hospital, 
                       National Institute of Siddha,   Tambaram Sanatorium, 
     Sample size:    40 Children  
Study period:   24 months. 
  
                           Clinical study 
Inclusion criteria   3 to 7 years. 
  both male & female children 
 Cough 
 Running  nose 
 Fever  on&off 
 Headache 
 Willing to give specimen of blood for investigation when 
required                 
 Willing to be admitted in the hospital or willing to attend 
OPD when required                 
  Willing to sign the informed, consent form 
 
Exclusion criteria 
 Children below 3 years and above 7 years of age 
 Continuous fever for 5 or more days 
 Signs of  moderate &severe  dehydration 
 H/o Childhood asthma 
 Patients with any other serious illness. 
Withdrawal criteria  Exacerbation of symptoms  
 Occurrence of any adverse effect  
 Patient turning unwilling during the course of trial drug  
Dosage of drugs  3 to 7yrs-1.6ml/bd 
Duration of treatment     3 days 
 
Investigation 
Routine blood: TC, DC, Hb 
Urine : Albumin, deposits. 
Siddha investigations : Neerkuri, Neikuri 
 
Study Enrollment: 
1. In this study, patients reporting at the NIS OPD with three or more clinical symptoms of 
cough, running nose, fever, headache, malaise, diarrhea were examined clinically for 
enrolling in this study based on the inclusion and exclusion criteria.  
2. The patients who are to be enrolled would be informed  about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to them and to their informants. 
3. After ascertaining the patient and informants willingness, informed consent was 
obtained in writing from them in the consent form (Form II). 
4. All these patients will be given unique registration card in which patients‘ Registration 
number of the study, Address, Phone number and Doctors phone number etc. were 
given, so as to report easily should any complications arise. 
5. Complete clinical history, complaints and duration, examination findings were recorded 
in the prescribed Proforma in the history and clinical assessment forms separately. 
Patients were advised to take the trial drug and appropriate dietary advice were given 
according to the patient informant‘s perfect understanding 
Conduct of the Study: 
The trial drug SIRUPULLADI ENNAI‖ was given continuously for 3 days. On the 4th day 
patient was  requested to attend the OPD for clinical assessment and it was  recorded in the 
clinical assessment form (Form IV) and prognosis noted. The patient‘s informant is requested 
to bring back the un-consumed trial drug if any. For IP patients the drug was provided daily 
and prognosis were noted. Laboratory investigations were done on the day before the start of 
my study and 4
th 
 day of the trial drug administration.  After the completion of the treatment, 
the patients were advised to visit our  OPD  on 7thday  for  follow up.  
  
Data Management: 
 After enrolling the patient in the study, a separate file for each patient was opened and 
all forms were filed in the file. Whenever study patient visits OPD during the study 
period, the respective patient file will be taken and necessary recordings will be made 
at the assessment form or other suitable form. 
  The screening forms were filed separately. 
 The Data recordings were monitored for completion and adverse event by HOD and 
data logical recording and completeness were monitored by statistician (Sr.Research 
Officer (Statistics)). All forms were further scrutinized in presence of Investigators by 
Sr.Research Officer (Statistics) for logical errors and incompleteness of data before 
entering onto computer to avoid any bias. No modification in the results is permitted 
for unbiased report. 
 Any missed data found in during the study, were collected from the patient, but the 
time related data will not be recorded retrospectively 
 All collected data weree entered using MS access software onto computer. 
 Investigators were trained to enter the patient data and cross checked by SRO 
Data Collection Forms:- 
 Screening  Form            
 Consent Form  
 Information Sheet  
 Case Report Form (CRF) 
 Drug Compliance  
 Withdrawl  Form 
 Adverse Reaction  
 Pharmacovigilance Form  
  
 
 
 
RESULTS AND OBSERVATIONS 
  
                6.  RESULTS AND OBSERVATIONS 
6.1 Preclinical studies 
6.1.1 In-vitro Anti-Inflammatory Activity by Protein (Albumin) denaturation Assay 
Absorbance Range of test and standard at Trial 1 
 
Absorbance Range of test and standard at Trial 2 
 
Absorbance Range of test and standard at Trial 3 
 
Table-6.1.1a 
Concentration µg/ml Absorbance 
Control 0.85  ± 0.05 
SPO 100 0.74  ± 0.03 
SPO 200 0.69  ± 0.04 
SPO 300 0.62  ± 0.04 
SPO 400 
0.50  ± 0.03 
SPO 500 0.43  ± 0.041 
Diclofenac sodium                
(100 µg) 0.02  ± 0.01 
Each value represents the mean ± SD. N=3 
Table-6.1.1b 
Concentration µg/ml Percentage Inhibition of Protein Denaturation 
SPO 100 3.275  ± 2.84 
SPO 200 8.609  ± 3.93 
SPO 300 16.97  ± 4.27 
SPO 400 29.84  ± 5.67 
SPO 500 
38.31  ± 0.39 
Diclofenac sodium                
(100 µg) 85.32  ± 2.685 
Each value represents the mean ± SD. N=3 
 
The result obtained from the present clearly indicates that the test drug SPO was effective in 
inhibiting heat induced albumin denaturation. Maximum percentage inhibition of about 38.31 
% was observed at 500 μg/ml when compare to that of the Diclofenac sodium, a standard 
anti-inflammatory agent with the maximum inhibition 85.32 % at the concentration of 100 
μg/ml. From the result of the study it was concluded that the test drug SPO possess 
convincing anti-inflammatory property in protein denaturation assay. 
 
6.1.2 Physicochemical Analysis: 
Table-5.1.2a 
Parameter Observation 
Color Yellowish Brown 
Smell Stringentodour 
Touch Oily 
Appearance Clear 
 
Table 6.1.2b 
 
S.No Parameter Mean (n=3) SD 
1 Loss on Drying at 105 °C (%) 2.83 ± 0.85 
2 Total Ash (%)  0.45 ± 0.12 
 
S.No Specific Test SPO 
1 PH  6 
2 Refractive index  1.49 
3 Iodoine value (mg I2/g) 118 
4 Saponification Value  (mg of KOH to saponi 1gm of fat) 194 
 
 
 
 
 
 
6.1.3  Phyto chemical Analysis: 
Test for Alkaloid- Mayer's reagent                                    Test for flavonoid 
                                                                        
 
 
Test for Glycosides -Borntrager‟s                                      Test for    Triterepnoids 
                                                                                
  
 
 
 
 Test for Steroids - Salkowski test                                              Test for tannins  
                                                                               
 
 
 
Test for Carbohydrate                                                 Phenol- Lead       acetate test                                                                                                                                                          
                                                       
  
 
 
 
 
Test for Saponins                                           Test for Proteins (Biuret Test) 
                                                                                  
 
 
Test of Coumarins                                                                 Test for anthocyanin 
                                                                                
 
 
 
Table-6.1.3 
PHYTOCOMPONENTS SPO 
Alkaloids - 
Flavonoids + 
Glycosides - 
Steroids + 
Sugar - 
Triterepnoids - 
Coumarins + 
Phenols + 
Tannins - 
Saponins + 
Proteins + 
Anthocyanin - 
 
+   Indicates positive;     - Indicates Negative 
 
61.4   BIOCHEMICAL ANALYSIS: 
Table: 6.1.4a   Acid radicals studies: 
S.No Parameter Observation Result 
1 Test for Sulphate Cloudy appearance  present Positive 
2 Test for Chloride Cloudy appearance    present Positive 
3 Test For 
Phosphate 
Cloudy  yellow     appearance 
absent 
Negative 
 
4 Test For 
Carbonate 
- Negative 
 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluoride 
&oxalate 
- Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Table: 6.1.4b . basic radicals studies 
  
S.No. Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium. - Negative 
4 Test For Iron. - Negative 
5 Test For Zinc - Negative 
6 Test for Calcium Cloudy appearance 
and white precipitate  
absent 
Negative 
7 Test For Magnesium 
 
White precipitate 
absent       
Negative 
8 Test For Ammonium 
 
Mild brown colour 
disappears 
Negative 
 
9 Test For Potassium - Negative 
10  Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
 
 
 
 
Table: 6.1.4c  Miscellaneous 
S.No Parameter Observation Result 
1 Test for Starch - Negative 
2 Test for Reducing sugars - Negative 
3 Test For Alkaloids. Yellow colour absent Negative 
4 Test For Tannic acid Blue-black precipitate absent Negative 
5 Test -unsaturated compounds - Negative 
6 Test for Type of compounds Green and Red colour   absent Negative 
 
The Bio chemical analysis of trial medicine showed the presence of Sulphate  and Chloride. 
 
6.2.1Clinical Studies 
40 Patients with confirmed diagnosis of Neer Kanamantham with satisfying the inclusion 
criteria were enrolled after obtaining written informed consent and were to receive 
Sirupulladi Ennai with dosage of 1.6 ml BID for 3days. 
Results were observed with respect to the following criteria 
1. Age, Sex, Parent‘s Socio Economic Status    
2. Diet 
3. Nilam 
4. Paruvakaalam 
5. Uyir thathukkal 
6. Ezhu udal kattugal 
7. Envagaithervugal 
8. Neikuri 
9. Cllinical features 
10. Haemotological Profile 
11. Biochemical Analysis 
 Table-6.2.2 Distributions of Childrens with NEER KANAMANTHAM  according to Age  
S.No Age No.of .cases Percentage 
1. 3-5 Years 25 62.5 
2. 6-7 Years 15 37.5 
 
 
Inference: 
 Out of 40 patients, 62.5 % of cases were 3-5 years, 37.5 % were 6-7 years.  
 
 
 
 
 
 
 
 
 
 
 
62.5%
37.5%
AGE
3-5 Years
6-7 Years
Table -6.2.3 Distributions of Children with NEER KANAMANTHAM according to Gender 
S.No Sex No of Cases Percentage 
1. Male Child 26 65 
2. Female Child 14 35 
 
 
Inference: 
Out of 40 patients 65% were male children and 35% were female children. 
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Table-6.2.4 Distribution of Children with NEER KANAMANTHAM according to socio-
economic status 
S.No 
Socio-economic 
Status 
No of Cases Percentage 
1. Upper  6 15% 
2. Upper Middle 10 25% 
3. Upper lower  17 42.5% 
4. Lower Middle 7 17.5% 
 
 
Inference: 
 About 15 % patients were under high income group, 25% patients were under 
upper middle class, 42.5 % patients were under upper lower class and 17.5 % patients were 
under lower middle class. The highest incidence occurred in Upper lower class. 
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Table-6.2.5 Distribution of Children with NEER KANAMANTHAM  according to Diet 
reference 
S.NO          Food habits No of cases Percentage 
1. Vegeterian 4 10 
2. Non-Vegeterian 36 90 
 
 
Inference: 
Out of 40 patients 10% were noted as vegetarian and 90% were noted as non vegetarian 
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Table -6.2.6 Distribution of Children with NEER KANAMANTHAM according to 
Nilam 
Nilam No of cases Percentage 
Kurinji 2 5 
Mullai 0 0 
Marutham 0 0 
Neithal 38 95 
Paalai 0 0 
 
 
Inference: 
Among 40 patients, 95 % were from Neithal land and remaining 5 % were from Kurinji 
land. 
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Table-6.2.7 Distribution of Children with NEER KANAMANTHAM according to 
Paruvakalam 
S.N
o 
Paruvakaalam No. of cases Percentage 
1. Karkaalam (Avani – puratasi) 0 0 
2. 
Koothirkaalam (Iyppasi – 
karthikai) 
0 0 
3. Munpani (Markazhi – Thai) 24 60 
4. Pin pani (Masi – Panguni) 16 40 
5. Elavenil (Chitirai, Vaigasi) 0 0 
6. Mudhuvenil (Aani, Aadi) 0 0 
 
 
Among 40 patients, 60 % were from Munpani kaalam,land, 40 % from Pinpani kaalam. 
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Table-6.2.8a Distribution of Children with NEER KANAMANTHAM according to 
derangement of Vatham 
S.No 
Classification of 
vatham 
No. of Cases Percentage 
1. Pranan 40 100 
2. Abanan 0 0 
3. Viyanan 0 0 
4. Uthanan 0 0 
5. Samanan 40 100 
6. Nagan 0 0 
7. Koorman 0 0 
8. Kirukaran 40 100 
9. Devadhathan 40 100 
10. Dhananjeyan 0 0 
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Inference: 
According to Vatham, all the 40 patients were observed with pranan, samanan, Kirukaran 
and Devadhathan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table-6.2.8b Distribution of Children with NEER KANAMANTHAM according to 
derangement of Pitham 
S.No Types of pitham No.of Cases Percentage 
1. Anal pitham 28 70 
2. Ranjagam 16 40 
3. Saathagam 40 100 
4. Prasagam 16 40 
5. Alosagam 0 0 
 
 
Inference: 
According to Pitham, derangement of Analapitham was 28%, Ranjagam and Prasagam 
was 16%, and Saathagam was 100 %  
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Table-6.2.8c Distribution of Children with NEER KANAMANTHAM according to de-
arrangement of Kabam 
S.No Types of Kabam No. of Cases Percentage 
1. Avalambagam 0 0 
2. Kilethagam 33 82.5% 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 0 0 
 
 
 
Inference: 
 According to Kabam, derangement of Avalambagam was 100 % and Kilethagam was 
70 %. 
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Table-6.2.9 Distribution of Children with NEER KANAMANTHAM according to 
derangement of Ezhu Udarkattugal 
S.No Udarkattugal No.of Cases Percentage 
1. Saaram 40 100 
2. Senneer 16 40 
3. Oon 0 0 
4. Kozhuppu 0 0 
5. Enbu 0 0 
6. Moolai 0 0 
7. 
Sukkilam/Suronit
ham 
0 
0 
 
 
 
Inference:  
Almost all the 40 cases were with saaram and 40% cases were with semeer. 
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Table-6.2.10 Distribution of Children with NEER KANAMANTHAM according to 
derangement of Enn vagai thervugal 
S.No 
Enn Vagai 
Thervugal 
No. of 
Cases 
Percen
tage 
1 Naa 15 37.5 
2 Niram 0 0 
3 Mozhi 25 62.5 
4 Vizhi 0 0 
5 Sparisam 20 50 
6 
Malam 
(Constipation) 
0 0 
7 Moothiram 0 0 
8 
Naadi 
Vathapitham 
Pithavatham 
Pithakabam 
 
26 
10 
4 
 
65 
25 
10 
 
 
 Inference: 
Out of 40 cases Low grade fever was observed in 50 % of the cases. 40% of the cases 
were affected by Naa, Niram and Vizhi. Sparisam was affected by 50 % cases. 15 % cases 
were affected by mozhi.  In Naadi, Vathapitham was observed in 65 % of cases, Pithavatham 
was observed in 25 % of cases and Pithakabam was observed in 10 % of cases.  
 
Table-6.2.11 Distribution of Children with NEER KANAMANTHAM according to 
observation of Neikuri analysis 
S. No 
Character of 
urine 
Neikuri 
Reference 
No.of Cases Percentage 
1. 
Spreads like 
snake 
Vatha Neer 20 50 
2. Spreads like ring Pitha Neer 12 30 
3. Static as pearl Kaba Neer 8 20 
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Inference: According to Neikuri, Vatha neer was observed in 50 of the % of cases, pitha 
neer was observed in 30 % of cases and Kaba neer was observed in 20 % of cases. 
 
Table-6.2.12a Distribution of Children with NEER KANAMANTHAM according to 
observation of  Clinical features 
Sl. No Clinical Features No. of  Cases Percentage 
1. Cough 40 100 
2 Rhinorrhoea 40 100 
3 Fever On & Off 15 37.5 
4 Headache 10 25 
5 Malaise 38 95 
6 Rumbling Noise In Abdomen 28 70 
7 Diarrhoea 0 0 
50%
30%
20%
Neikuri analysis
Spreads like snake
Spreads like ring
Static as pearl
  
Among 40 patients,100% of them had cough and rhinorrhoea,95% had malaise 70% had 
rumbling noise in abdomen,37.5% had  fever on & off,25% had headache. 
 
Table-6.2.12 b  Distribution of Children with NEER KANAMANTHAM according to 
observation  before and after treatment of Cough assessement: 
Before Treatment 
S. No. Cough assessment questions No. of Cases  % of Cases 
1 Chest  pain or  stomach  pain  during  cough 20 50% 
2 Sputum  production  while  coughing 3 7.5% 
3 Sleep disturbances due to cough. 30 75% 
4 Cough  interrupting  conversation 22 55% 
5 Cough present at rest. 20 50% 
 
After Treatment 
S. No. Cough assessment questions No  of Cases  % of Cases 
1 Chest  pain or  stomach  pain  during  cough 10 25% 
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2 Sputum  production  while  coughing 1 2.5% 
3 Sleep disturbances due to cough. 10 25% 
4 Cough  interrupting  conversation 12 30% 
5 Cough present at rest. 5 12.5% 
 
 
 
 
Table- 6.2.12c  Cough Assessment score - Before and after treatment: 
Before 
Treatment Score 
After Treatment Score 
0 2 4 Total 
2 8 0 0 8 
4 1 12 3 16 
6 0 8 1 9 
8 0 4 3 7 
Total  9 24 7 40 
0%
10%
20%
30%
40%
50%
60%
70%
80%
50%
7.50%
75%
55%
50%
25%
2.50%
25%
30%
13%
Before Treatment
After Treatment
In the above assessment 8, 16, 9 and 7 patients were scored 2, 4, 6 and 8 respectively; which 
represents 16/40 patients scored more than 4 before treatment. However none of the patients 
scored more than 4 after treatment. It reveals that the treatment has influenced in reducing the 
severity of the clinical conditions. There are 24 and 7 patient cough assessment score after s 
repoted with 2 and 4 assessment score respectively.  Nine patients who are with the score of 
2(8 patients), 4(1 patient) have shown no symptoms of cough. 
 
Table-6.2.12d    Cough Assessment  score –before and after treatment 
 
The treatment has effect of 60% in reducing the severity in clinical condition of cough which 
is statistically significant. There is difference between mean value before and after treatment 
of cough assessment. 
 
Table-6.2.13 Distribution of Childrens with NEER KANAMANTHAM according treatment 
results obtained 
 
 
Cough 
Assessment Score 
       Mean ± Std        T value          P value 
Before 4.75±2.0                
          11.54 
 
                 
       P < 0.001 
 
After 1.9±1.27 
S. No Results No. of Cases Percentage 
1. Good Relief 26 65 
2. Moderate Relief 10 25 
3. Mild  Relief 4 10 
Inference: 
Out of the 40 cases, the signs and symptoms were reduced markedly in 65% of cases, 
moderately in 25% of cases and mildly in 10% of cases. These results were based on the 
clinical improvements observed. 
 
LAB INVESTIGATION-BEFORE TREATMENT LAB INVESTIGATION 
DC: Differential count, P: Polymorphs, L: lymphocytes, M: Monocytes, E: Eosinophils,  
B: Basophils 
Lab Investigation 
S.NO 
OP. No./   
IP. No. 
 
AGE/ 
YRS 
 
SEX 
HB(%) 
TC Cells 
cu/mm 
RBC 
10
6
 
Cells/cu.                      
mm 
 
AEC 
 
ESR 
½hr 
ESR 1 
hr 
  BT BT BT BT BT BT 
1 I50929 3 FC 12.0 12400 4.7 362 6 12 
2 E053485 6 FC 12.5 8000 5.2 
412 9 20 
3 I40713 5 FC 11.2 12000 4.8 
342 2 6 
4 
D06702
5 
3 MC 
10.4 7600 5.1 
352 4 10 
5 H54046 5 MC 11.6 9600 4.6 
326 6 14 
6 
I34139 7 MC 
11.0 7000 4.6 
372 5 12 
7 I38442 5 MC 12.5 7800 4.8 
462 10 22 
8 I48279 5 FC 10.5 13500 5.1 
368 6 14 
9 
I00036 4 MC 
11.0 11000 5.2 
316 20 46 
1 
H03228 3 
½ 
FC 
10.7 10500 4.7 
342 12 24 
11 I62355 3 MC 12.4 8100 4.9 
321 4 10 
12 I40279 5 FC 10.4 8400 4.5 
295 5 12 
13 H53886 3 FC 12.2 6600 4.3 
310 8 18 
14 
I62408 7 MC 
10.5 7300 4.5 
423 9 20 
15 E550101 5 MC 10.4 6000 5.6 
298 2 4 
16 I62711 6 MC 12.6 8800 4.5 
422 6 14 
17 I71980 3 FC 10.4 7800 5.1 
387 2 4 
18 I71965 4 FC 12.5 9700 4.8 
427 10 24 
19 I71908 7 MC 12.3 13500 4.9 
310 12 24 
20 I62761 7  MC 10.7 9600 5.2 
360 4 10 
21 I72398 6 MC 12.4 6900 4.7 
340 4 8 
22 I72412 4 MC 12.7 7400 4.7 
390 12 25 
23 I62528 5 MC 10.8 9300 5.6 
360 2 4 
24 
I03504 4 
½ 
MC 
12.8 9900 4.6 
310 12 26 
25 
I59243 4 
½ 
MC 
11.8 6600 4.9 
322 2 4 
26 G86487 5 MC 12.8 13700 4.9 
366 12 26 
27 I75050 7 MC 12.3 5100 4.7 
345 2 5 
28 I75387 3 MC 12.6 9800 4.7 
340 6 12 
29 H53619 3 FC 12.2 10600 4.6 
292 4 10 
30 I81173 7 FC 12.3 7900 4.5 
368 2 6 
31 H97704 7 MC 11.7 8100 4.6 
290 2 4 
32 
G06878 4 
½ 
FC 
12.2 12900 4.2 
289 8 20 
33 I81704 5 FC 12.6 7900 4.8 
400 2 6 
34 I43982 6 MC 12.1 8100 4.3 
240 2 4 
35 I40107 7 MC 12.5 8000 4.2 
230 2 4 
36 2087 7 MC 12.3 7200 4.3 
329 2 6 
37 2093 3 MC 12.2 7000 4.5 
322 3 8 
38 2094 3 MC 10.5 10000 4.7 
260 16 34 
39 2089 6 FC 12.2 6300 4.3 
297 4 8 
40 2045 7 MC 12.5 7200 4.6 
366 2 6I 
 
HB: Haemoglobin level, TC: Total count, AEC: Absolute eosinophil count 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LAB INVESTIGATION 
 
S.No 
OP No /  
IP No. 
Age Sex P L M E B 
 BT BT BT BT BT 
1 I50929 3 FC 32 54 1 4 1 
2 E053485 6 FC 56 38 - 8 - 
3 I40713 5 FC 52 44 - 4 - 
4 D067025 3 MC 33 62 7 - - 
5 H54046 5 MC 40 53 5 6 1 
6 I34139 7 MC 42 52 4 6 - 
7 I38442 5 MC 67 23 - 5 - 
8 I68878 5 FC 55 40 5 5 - 
9 I00036 4 MC 50 48 - 5  - 
10 H03228 3 ½ FC 45 50 1 4 - 
11 I62355 3 MC 72 33 - 5 - 
12 I40279 5 FC 49 45 - 6 - 
13 H53886 3 FC 41 51 - 8 - 
14 I62408 7 MC 47 52 - 1 - 
15 E550101 5 MC 51 42 - 1 - 
16 I62711 6 MC 57 44 2 7 - 
17 I71980 3 FC 54 37 - 9 - 
18 I71965 4 FC 17 32 3 8 - 
19 I71908 7 MC 65 29 4 4 2 
20 I62761 7  MC 52 40 3 4 1 
21 I72398 6 MC 32 64 - 4 - 
22 I72412 4 MC 42 50 6 2 - 
23 I62528 5 MC 48 48 6 1 - 
24 I03504 4 ½ MC 30 50 1 6 - 
25 I59243 4 ½ MC 56 39 1 4 - 
26 G86487 5 MC 46 47 6 1 - 
27 I75050 7 MC 42 28 - 5 - 
28 I75387 3 MC 38 54 3 4 1 
29 H53619 3 FC 37 58 3 2 0 
30 I81173 7 FC 45 48 4 2 1 
31 H97704 7 MC 39 55 3 3 1 
32 G06878 4 ½ FC 60 33 3 3 1 
33 I81704 5 FC 45 50 2 3 - 
34 I43982 6 MC 58 32 4 2 1 
35 I40107 7 MC 61 30 4 4 1 
36 2087 7 MC 46 26 2 6 1 
37 2093 3 MC 58 36 2 8 - 
38 2094 3 MC 52 43 6 - - 
39 2089 6 FC 75 42 3 1 - 
40 2045 7 MC 42 26 3 2 - 
 
DC: Differential count, P: Polymorphs, L: lymphocytes, M: Monocytes, 
 E: Eosinophils, B: Basophils 
 
 
 
LAB INVESTIGATION 
 
S. No  OP. No.  
Age Sex 
Alb 
Su Deposits 
  BT BT        BT 
1 
I50929 3 FC Nil  Nil  
 2-8Pus,2-4Epi 
2 E053485 6 FC Nil  Nil  2-4Pus, 2-4 Epi 
3 I40713 5 FC Nil  Nil  2-4Pus, 2-4Epi 
4 D067025 3 MC Nil  Nil  1-2Pus, 2-4 Epi 
5 H54046 5 MC Nil  Nil  4-6 Pus&1-2Epi 
6 I34139 7 MC Nil  Nil  4-6Pus, 6-8 Epi 
7 I38442 5 MC Nil  Nil  3-5Pus, 4-6 Epi 
8 
I68878 5 FC Nil  Nil  
4-6 Pus&1-2Epi 
9 I00036 4 MC Nil  Nil  3-5Pus, 4-6Epi 
10 H03228 3 ½ FC Nil  Nil  4-6Pus, 2-4Epi 
11 I62355 3 MC Nil  Nil  1-2Pus, 2-4 Epi 
12 
I40279 5 FC Nil  Nil  
1-2Pus,1,2Epi 
13 H53886 3 FC Nil  Nil  1-2 Pus 2-4Epi 
14 I62408 7 MC Nil  Nil  1-2 Pus,2-3 Epi 
15 E550101 5 MC Nil Nil 3-5Pus, 2-4 Epi 
16 I62711 6 MC Nil Nil 1-2Pus, 2-4 Epi 
17 I71980 3 FC Nil  Nil  2-3Pus, 2-Epi 
18 I71965 4 FC Nil  Nil  1-2Pus, 2-4 Epi 
19 I71908 7 MC Nil  Nil  2-3Pus, 1-2Epi 
20 I62761 7  MC Nil  Nil  1-2 Pus,2-4 Epi  
21 I72398 6 MC Nil  Nil  2-3Pus, 2-3 Epi 
22 I72412 4 MC Nil  Nil  2-3 Pus, 1,2Epi 
23 I62528 5 MC Nil  Nil  2-4Pus,1-2 Epi 
24 I03504 4 ½ MC Nil  Nil  2-4 Pus 2-4Epi 
25 I59243 4 ½ MC Nil  Nil  2-4Pus,1-2 Epi 
26 G86487 5 MC Nil  Nil  3-2Pus2-4Epi 
27 I75050 7 MC Nil  Nil  3-5Pus, 2-4Epi 
28 I75387 3 MC Nil  Nil  1-2Pus , 1-2Epi 
29 H53619 3 FC Nil  Nil  1-2Pus, 2-4 Epi 
30 I81173 7 FC Nil  Nil  2-4Pus, 2-4Epi 
31 H97704 7 MC Nil  Nil  1-2Pus, 2-4 Epi 
32 G06878 4 ½ FC Nil  Nil  2-5Pus, 2-3 Epi 
33 I81704 5 FC Nil  Nil  2-4Pus, 2-4 Epi 
34 I43982 6 MC Nil  Nil  1-2Pus, 1-2Epi 
35 I40107 7 MC Nil Nil 2-3Pus, 1-2Epi 
36 2087 7 MC Nil Nil 1-2Pus, 2-4 Epi 
37 2093 3 MC Nil Nil 1-2Pus, 2-4 Epi 
38 2094 3 MC Nil Nil 2-4Pus, 2-4 Epi 
39 2089 6 FC Nil Nil 2-4Pus, 2-4 Epi 
40 2045 7 MC Nil Nil 1-2Pus, 2-4 Epi 
 
 
 
 
 
 
 
 
 
 
 
 
  
DISCUSSION 
  
              7.  DISCUSSION 
Neerkanamantham is an Upper Respiratory Tract Infections which is one of the most 
common medical problems in the daily lives of people worldwide. Various signs and 
symptoms of this disease have been characterised as cough, runny nose, frequent fever, head 
ache, malaise, and rumbling noise in abdomen. In the present study, thirty five cases were 
treated in the outpatient department, and five cases have been admitted in the inpatient 
department and treated with Sirupulladi Ennai which has been mentioned mentioned in the 
Sasthric Siddha literature Balavagadam having the indication to treat Kanam. Since all the 
ingredients of this medicine are purely herbal it is safe and have good efficacy in treating 
Neerkanamantham in children. The diagnosis is based on clinical observation and laboratory 
investigations. The diagnosis is confirmed and treated with the drug ―Sirupulladi Ennai‖ and 
the improvements are clearly observed. 
The drugs which are mentioned in Siddha literature for the management of 
neerkanamantham were selected and the study is conducted after the proposal was screened 
by the Screening committee of National Institute of Siddha. The Clinical study has been 
approved by IEC of NIS, approval (…………). The trial is registered in Clinical trial 
Registry of India with Reg.No.CTRI/2017/05/008641.The Authentication of ingredients of 
the trial drug was done obtained from Medicinal Botanist, National Institute of Siddha, 
Chennai. 
The trial drugs were prepared in the Gunapadam practical laboratory of National 
Institute of Siddha, after getting proper authentication of raw drugs from the Medicinal 
botany department at NIS, Chennai 47. The trial drug was prepared by the standard operating 
procedure as mentioned in the protocol. 
 
 
In-vitro anti-inflammatory activity Sirupuladi Oil (SPO) was studied using albumin 
denaturation technique. The reaction mixture consisted of bovine serum albumin (5% 
aqueous solution) and test sample SPO at varying concentration ranges from 100 to 500 
mcg/ml and standard diclofenac sodium at the concentration of100 mcg/ml of final volume. 
pH was adjusted by using a small amount of 1N Hydrochloric acid. The samples were 
incubated at 37°C for 20 min and then heated at 57°C for 3 min. After cooling the sample, 2.5 
ml of phosphate buffer solution was added into each test tube. Turbidity developed was 
measured spectrophoto-metrically at 660 nm, for control distilled water was used instead of 
test sample while product control tests lacked bovine serum albumin. 
The result obtained from the present clearly indicates that the test drug SPO was effective in 
inhibiting heat induced albumin denaturation. Maximum percentage inhibition of about 38.31 
% was observed at 500 μg/ml when compare to that of the Diclofenac sodium, a standard 
anti-inflammatory agent with the maximum inhibition 85.32 % at the concentration of 100 
μg/ml. 
Physico chemical analysis 
Physico chemical analysis was done as a preliminary evaluation on the trial drug Sirupulladi 
Ennai. Iodine value, Saponification value is used to measure the relative degree of 
unsaturated fatty acid in the sample. Smaller the molar weight of the fat higher the 
saponification value.The saponification value indicates the mean molecular weight of fatty 
acid of triglycerides comprising of fat. Lower the saponification value larger the molecular 
weight of fatty acids and triglyceride vice versa. Since the Iodine & saponification value is 
118 & 194 respectively which interprets low molecular weight of the fatty acids and 
triglycerides. 
 
The refractive index is a measure of purity of a sample. It is a ratio of velocity of light in 
vacuum. If any adulteration is present in the sample the refractive index will increase or 
decrease, which is very helpful in determination of unsaturation. Refractive index increases 
with increase in unsaturation. Since the refractive index is 1.49 it interprets that there is no 
adulteration in the experimental formulation and degree of unsaturation is low. 
Ash values may be effective parameter to assess the degree of purity of a given drug. The ash 
value indicates the presence of inorganic contents in the sample.  Total ash usually consists of 
carbonates, phosphates, silicates and silica which include both physiological ash-which is 
derived from the plant tissue itself and non physiological ash which is the residue of the 
adhering material to the plant surface. The Standard references of ash value according to the 
European Pharmacopoeia maximum acceptable limit of total ash is 14 % and Acid insoluble 
Ash is 2%. From the result obtained for the ash test of Sirupulladi ennai, the total ash is found 
to be within the limit which in turn indicates the prepared drug is pure. 
Loss on Drying at 105°C indicates that only 2.83% of water and volatile components have 
been lost when 1g of the prepared drug was kept at 105°C. This moisture content helped to 
prevent deprivation of efficacy and degeneration of the drug. High moisture content can 
adversely affect the active principles of the drug which may possibly get early infection of 
the drug. Thus low moisture content could get maximum stability and long life. 
It is the measure of the acidity or alkalinity of a drug. The pH of any drug is the measure of 
its hydrogen ion (H
+
) concentration relative to that of a given standard solution. The pH 
may range from 0 to 14, where 0 is most acid, 14 most basic, and 7 is neutral. In the prepared 
drug the pH level is found to be 6. 
 
 
Phyto chemical Analysis 
Phyto chemical Analysis has been carried out in the trail drug Sirupulladi Ennai and it is 
found that the presence of flavonoids, steroids, coumarins, phenols, saponins and proteins are 
found to be positive and the presence of alkaloids, glycosides, sugar, triterepnoids, tannins 
and anthocyanin are found to be negative. 
Flavonoids are potent antioxidants and have anti-inflammatory as well as anti-allergic 
actions. In addition to reducing oxidative stress, in vitro experiments have found that many 
individual flavonoids have inhibitory effects on IgE mediated immune responses such as 
histamine secretion by mast cells, shift in cytokine production from Th-2 to Th-1 production 
and decreased NF-κB activation and inhibition of TNF-α. The biological functions of 
flavanoids apart from its antioxidant properties include protection against allergies, 
inflammation, free radicals, platelet aggregation and microbes. 
Steroids have been shown to help relieve symptoms in other types of upper 
respiratory tract infections by reducing the inflammation of the lining of the nose and throat, 
which means they might also improve the symptoms of the common cold. 
The phenolic compounds are one of the largest and most ubiquitous groups of plant 
metabolites. They possess biological properties such as, antiinflammation, and improvement 
of endothelial function, as well as inhibition of angiogenesis and cell proliferation activities 
Saponins natural tendency to ward off microbes makes them good candidates for treating 
infections. These compounds served as natural antibiotics, which help the body to fight 
infections and microbial invasion. 
 
Bio chemical analysis 
The Bio chemical analysis of trial medicine showed the presence of Sulphate and Chloride 
which states that the prepared medicine acts as a good expectorant which in turn reduces the 
symptoms of cough. 
Clinical studies 
In clinical studies the patients were recruited for the trial based on inclusion and exclusion 
criteria and after getting the consent from the patient. 40 patients were included in this study. 
35 patients were treated in OPD and 5 patients were treated in the IPD of Ayothidoss 
Pandithar Hospital of National Institute of Siddha. Separate proforma was maintained for 
every patient. Progress chart was also maintained to monitor the clinical signs and symptoms 
of the disease.  
The treatment was aimed at normalizing the deranged thodams and providing relief from 
symptoms. Before treatment the patients were advised to adapt lifestyle modifications with 
good dietary regimen. 
The patients were treated with trial drugs Sirupulladi Ennai for 3 days. Patients were instructed 
to take the medicines regularly and advised to follow pathiyam and to avoid exposure to 
allergic substances if any. Out Patients were asked to visit the hospital on 4
th
 day. After 
completion of the study; the patients were advised to visit the Out-Patient ward of 
Department of Kuzhanthai Maruthuvam on the seventh day for follow-up. The results 
observed during the study period were discussed below.   
This study evaluates the effect of ―Sirupulladi Ennai‖ in relieving the symptoms of 
Neerkanamantham. 
 
 
Clinical Studies 
Age: 
Out of 40 patients, 62.5 % of cases were 3-5 years, 37.5 % were 6-7 years.  
Gender 
Out of 40 patients 65% were male children and 35% were female children. 
Socio-economic status 
About 15 % patients were under high income group, 25% patients were under upper middle 
class, 42.5 % patients were under upper lower class and 17.5 % patients were under lower 
middle class. The highest incidence occurred in Upper lower class. 
Diet reference 
Out of 40 patients 10% were noted as vegetarian and 90% were noted as non vegetarian 
Nilam 
Among 40 patients, 95 % were from Neithal land and remaining 5 % were from Kurinji land. 
Paruvakalam 
Among 40 patients, 60 % were from Munpani kaalam,land, 40 % from Pinpani kaalam. 
Vatham 
According to Vatham, all the 40 patients were observed with pranan, samanan, Kirukaran and 
Devadhathan. 
Pitham 
According to Pitham, derangement of Analapitham was 28%, Ranjagam and Prasagam was 
16%, and Saathagam was 100 %  
Kabam 
According to Kabam, derangement of Avalambagam was 100 % and Kilethagam was 70 %. 
Ezhu Udarkattugal 
Almost all the 40 cases were with saaram and 40% cases were with semeer. 
Enn vagai thervugal 
Out of 40 cases Low grade fever was observed in 50 % of the cases. 40% of the cases were 
affected by Naa, Niram and Vizhi. Sparisam was affected by 50 % cases. 15 % cases were 
affected by mozhi.  In Naadi, Vathapitham was observed in 65 % of cases, Pithavatham was 
observed in 25 % of cases and Pithakabam was observed in 10 % of cases.  
Neikuri analysis 
According to Neikuri, Vatha neer was observed in 50 of the % of cases, pitha neer was 
observed in 30 % of cases and Kaba neer was observed in 20 % of cases. 
Statistical Analysis (cough) 
The treatment has effect of 60% in reducing the severity in clinical condition of cough which 
is statistically significant.  
Improvement in clinical features: 
Out of the 40 cases, the signs and symptoms were reduced markedly in 65% of cases, 
moderately in 25% of cases and mildly in 10% of cases. These results were based on the 
clinical improvements observed. 
From the above results the chosen drug Sirupulladi Ennai is very effective and it is suggested for 
the treatment of Neerkanamantham in children. 
 
 
 
 
 
 
SUMMARY 
  
                                     8. SUMMARY 
The literature evidence of both the siddha and modern literatures were reviewed and the 
reviews and recent studies on the individual drugs of the trial drug were collected. Patients 
attending the OPD and IPD of NIS having the complaints of NEERKANAMANTHAM are 
diagnosed clinically.  
Sirupulladi Ennai was selected as the drug for the management of NEERKANAMANTHAM. 
The study is conducted after the proposal was screened by the Screening committee of 
National Institute of Siddha. The Clinical study has been approved by IEC of NIS. The trial is 
registered in Clinical trial Registry of India. The Authentication of ingredients of the trial 
drug was done obtained from Medicinal Botanist NIS. The trial drugs were prepared by the 
author in the Gunapadam practical laboratory of National Institute of Siddha, after getting 
proper authentication of raw drugs from the Medicinal botany department at NIS. The trial 
drug was prepared by the standard operating procedure as mentioned in the protocol. 
The drug is found to have with good anti inflammatory activity.  
The physicochemical analysis reveals high saponification value, Good refractive index and    
total Ash value is limited, low moisture content. Phyto chemical Analysis has been carried 
out in the trail drug Sirupulladi Ennai and it is found that the presence of flavonoids, steroids, 
coumarins, phenols, saponins and proteins are found to be positive and the presence of 
alkaloids, glycosides, sugar, triterepnoids, tannins and anthocyanin are found to be negative. 
The Bio chemical analysis of trial medicine showed the presence of Sulphate, and Chloride. 
The patients have not complained of any adverse effects or difficulties during the 
course of treatment. Thus the drug is found to be safe and effective in the management of 
neerkanamantham. The observations made during the clinical study showed that the trail drug 
sirupulladi ennai was clinically effective. 
  
 
 
 
 
 
 
 
 
                    
 
 
 CONCLUSION 
LAB INVESTIGATION 
 
S.No 
OP No /  
IP No. 
Age Sex P L M E B 
 BT BT BT BT BT 
1 I50929 3 FC 32 54 1 4 1 
2 E053485 6 FC 56 38 - 8 - 
3 I40713 5 FC 52 44 - 4 - 
4 D067025 3 MC 33 62 7 - - 
5 H54046 5 MC 40 53 5 6 1 
6 I34139 7 MC 42 52 4 6 - 
7 I38442 5 MC 67 23 - 5 - 
8 I68878 5 FC 55 40 5 5 - 
9 I00036 4 MC 50 48 - 5  - 
10 H03228 3 ½ FC 45 50 1 4 - 
11 I62355 3 MC 72 33 - 5 - 
12 I40279 5 FC 49 45 - 6 - 
13 H53886 3 FC 41 51 - 8 - 
14 I62408 7 MC 47 52 - 1 - 
15 E550101 5 MC 51 42 - 1 - 
16 I62711 6 MC 57 44 2 7 - 
17 I71980 3 FC 54 37 - 9 - 
18 I71965 4 FC 17 32 3 8 - 
19 I71908 7 MC 65 29 4 4 2 
20 I62761 7  MC 52 40 3 4 1 
21 I72398 6 MC 32 64 - 4 - 
22 I72412 4 MC 42 50 6 2 - 
23 I62528 5 MC 48 48 6 1 - 
24 I03504 4 ½ MC 30 50 1 6 - 
25 I59243 4 ½ MC 56 39 1 4 - 
26 G86487 5 MC 46 47 6 1 - 
27 I75050 7 MC 42 28 - 5 - 
28 I75387 3 MC 38 54 3 4 1 
29 H53619 3 FC 37 58 3 2 0 
30 I81173 7 FC 45 48 4 2 1 
31 H97704 7 MC 39 55 3 3 1 
32 G06878 4 ½ FC 60 33 3 3 1 
33 I81704 5 FC 45 50 2 3 - 
34 I43982 6 MC 58 32 4 2 1 
35 I40107 7 MC 61 30 4 4 1 
36 2087 7 MC 46 26 2 6 1 
37 2093 3 MC 58 36 2 8 - 
38 2094 3 MC 52 43 6 - - 
39 2089 6 FC 75 42 3 1 - 
40 2045 7 MC 42 26 3 2 - 
 
DC: Differential count, P: Polymorphs, L: lymphocytes, M: Monocytes, 
 E: Eosinophils, B: Basophils 
 
                                    9. CONCLUSION 
                 The Siddha system of medicines has certainity with safer medications to treat 
children. In the present study, the trial drug sirupulladi ennai is used for the treatment of 
children of age group, 3-7 years who are all diagnosed to have neerkanamantham. The 
ingredients of  sirupulladi ennai are feasible and useful.  These  may serve as potentially a 
useful drug at a lower cost since most of them had anti-inflammatory activity and the 
physicochemical analysis reveals high saponification value, Good refractive index and    total 
Ash value is limited  , low moisture content. 
Phyto chemical Analysis has been carried out in the trail drug Sirupulladi Ennai and it is 
found that the presence of flavonoids, steroids, coumarins, phenols, saponins and proteins are 
found to be positive. The Bio chemical analysis of trial medicine showed the presence of 
Sulphate,  and Chloride. Clinical results were found to be significant. Good improvement was 
found in 65% of the cases, moderately in 25% of cases and mildly in 10% of cases. The 
present clinical study has established that sirupulladi ennai is having good result in reducing 
the majority of the symptoms of neerkanamantham. This in turn, provided a further research 
and opportunity for new drug established in the management of neerkanamantham. 
By encouraging results of above study the drug may be taken for larger study in treatment 
of neerkanamantham. 
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CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR  THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 
1.  S.No:               2. OP/ IP No:                           3.Name:          
4.Age:     5.Gender:   6.Date :       
7.Informant:    8.Reliability:    
 
SCREENING  Form 
INCLUSION CRITERIA: 
               YES        NO 
Age: between 3-7 years 
Cough   
Running nose        
Fever  on & off                
            Head ache     
EXCLUSION CRITERIA  
Children < 3 and >7 years  
Fever more than 5 days  
      Childhood  asthma 
  Primary complex  
 Signs of moderate and 
severe dehydration 
Any other serious illness 
 
 ADMITTED TO THE STUDY 
If Yes,        OPD  IPD 
 
 
Signature of Lecturer:     
 
Signature of HOD                                                          Signature of Principal Investigator 
 
 
 
 
 
 
 
 
 
 
 
  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR THE  
                 TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN.  
 CASE RECORD FORM 
Demographic data 
 Patient Id : OP/IP No: Visit Date : 
Name :  
Age    :  
Gender                Male             Female Date Of Birth :  
Father/ Mother /Guardian Name : 
 
 
Father
,
 s Occupation : 
 
 
Father
,
sMonthly  Income : 
 
 
Religion : 
 
 
 
Socioeconomic Status : 
 
 
Informant : 
 
 
Postal Address 
 
 
 
Contact No.  
1.COMPLAINTS AND DURATION:  
 
          
 
2.HISTORY OF  PRESENT ILLNESS : 
 
 
 
3. HISTORY OF PAST ILLNESS: 
   History /Symptoms/Signs  Yes  No  If, Yes Details 
  Any Similar Complains  
  Bronchial Asthma 
  Dust Allergy 
  Hospitalization 
  Any other                             _____________ 
 
 
4. FAMILY HISTORY: 
Any Hereditary/ Familial Disease     Yes                      No 
 If Yes, Details ------------------------------- 
 
5.  Immunisation History  
Proper Immunization given  Yes                     No           
............................................... 
 
 
 
 
 
6. FOOD HABITS 
 
   1.    Veg  2. Non-Veg  3. Mixed 
General assessment 
1. Pica                      YES                      NO                         
2. Nail biting               YES                         NO   
3. Bowel movements      Normal                  Abnormal                 
 
 
b) Palpation:ss 
Tenderness                  Yes
 Gen
eral  examination 
Pallor               YES            NO 
Jaundice               YES            NO 
Cyanosis               YES            NO 
Clubbing               YES            NO 
Pedal oedema               YES                      NO 
Lymph adenopathy                      YES            NO 
 
Vital signs:- 
 Pulse rate                                           / min 
 Heart rate                                           / min 
 Respiratory Rate                                / min 
 Temperature               / ◦F 
 
Anthropometry:- 
          Height :                  cm 
          Weight :                  Kg 
              
 
  Systemic examination  
                                   Examination of  Respiratory system 
A)     Inspection: 
Shape                           : Normal    Barrel Shaped Pigeon chest 
Shoulder Drooping       :  Absent                Present 
 Inter costal spaces       :   Normal              Bulge                          In-drawing 
 Spine                           :  Normal               Kyphosis                        Scoliosis 
 Supraclavicular fossae: Normal                Flattening                     Hollowing 
      
Position of mediastinum: 
 Trail‘s sign:   Present               Absent 
 Apical impulse-------------------------------No 
                                   If yes___________ 
Tactile vocal Fremitus:        Normal and equal   
                                             Increased 
         Decreased 
 C)  Percussion:         
Percussion on all  areas:                 Normal                     
        Hyper resonance                                                            
        Dullness 
D)   Auscultation:  
Intensity of breath sounds: 
                           Normal                   decreased                        increased           
Vocal resonance :  
                          Normal                    decreased                        increased                    
 Adventitious sounds 
              Wheeze   Crepitation  Rub        None   
Other system;                                  Normal                         Affected 
Cardio vascular system   : 
Gastro intestinal system: 
Musculo Skeletal system :  
Central nervous system   : 
Endocrine system            : 
Nilam:-  
           Kurinji           Mullai            Marutham            Neithal            Paalai 
Kaala Iyalbu:-  
 Kaarkalam   Koothirkaalam  Munpanikaalam 
 Pinpanikaalam                       Illavenirkaalam                Muthuvenirkaalam 
Yaakai 
 Vatham  Vatha Pitham              Vatha Kabam 
 Pitham   Pitha vatham   Pitha Kabam 
 Kabam   Kaba Vatham   Kaba Pitham 
Gunam 
            Sathuvam  Rasatham   Thamasam 
Pori / Pulangal 
  Normal Affected    Normal    Affected     Remarks 
Mei/ unarvu                                                         
Vaai/ suvai        
Kan/ parvai   
Mooku/ natram/      
Sevi /  olli 
         
Kanmendhirium / Kanmavidayam 
       Normal     Affected       Normal            Affected  Remarks 
Kai / dhanam 
Kaal / ghamanam 
Vaai / vaku  
Eruvai / visarkam 
Karuvai / anantham 
Uyir Thathukkal 
 Vatham;  Normal   Affected  Remarks 
Pranan  
Abanan 
Viyanan  
Uthanan 
Samanan 
Nagan  
Koorman 
Kirukaran  
Devathathan   
Dhanajeyan    
 
Pitham  
   Normal Affected  Remarks 
Analam  
Ranjagam    
Saathagam   
Alosagam   
Prasagam 
Kabam 
          Normal            Affected  Remarks 
Avalambagam    
Kilethagam   
Pothagam  
Tharpagam   
Samthigam  
Udalthathukkal 
   Normal Affected  Remarks 
Saaram 
Senneer  
Oon 
Kozhuppu 
Enbu 
Moolai 
Sukilam / Suronitham   
EnvagaiThervugal  
                                  Normal  Affected  Remarks 
A)Naa  
 Niram 
 Thanmai 
 Suvai 
b)Niram   
c)Mozhi   
 
 
d)Vizhi              Normal Affected  Remarks 
               Niram 
         Thanmai  
              Parvai 
e)Sparisam  
f)Malam 
 Niram     
 Nurai     
 Elagal    
 Erugal    
  
g ) Moothiram  
Neerkuri:      
           Niram     
      Edai     
      Nurai   
      Manam            
      Enjal     
Neikuri:       
 Vatham                  Pitham             Kabam         Others 
h)Naadi:   
      Vadham       Pitham    Kabam 
      Vatha pitham      Pitha vatham Kaba vatham          
     Vatha kabam     Pitha kabam            Kaba pitham 
 
 
 
 
 
 
 
 
  
CLINICAL ASSESSMENT : 
COUGH  ASSESSEMENT: 
                                     
[Each  item  carries  two  points  and  the  total  score  will  be  assed  from  the  
following] 
                                                                  
                                                                                       1
st
 day             4
th
 day                             
11.Had  chest  pain or  stomach  pain  during  cough 
 
2..Sputum  production  while  coughing 
 
3. Sleep  disturbances  due  to  cough.  
 
S.NO CLINICAL 
SYMPTOMS 
1
st 
day 4
th
day 
 
1. Cough   
2. Running nose   
3. Fever  on&off   
4. Headache   
5. Malaise    
6. Rumbling noise in 
abdomen  
  
7. Diarrhoea   
4.. Cough  interrupting  conversation  
 
5 .Cough  present  at  rest.  
Laboratory Investigations: 
 
Diagnosis   ---------------------------------------- 
   
Drug Issued: --------------------------------------    
Date  :                                                           
Station :   
 
ROUTINE BLOOD 
INVESTIGATIONS 
NORMAL 
VALUES 
 
BEFOR
E TMT 
Date: 
 
AFTER 
TMT 
Date: 
Hb ( gms%)  11.5 – 14.5    
T.RBC (milli /cu.mm)        4-4.9   
 
ESR (mm) 
½ hr. 0- 4   
1 hr.        0-13   
T.WBC (milli /cu.mm) 5000-14500   
DIFFERENTIA
L COUNT (%) 
Polymorph
s 
40-75   
Lymphocy
tes 
28-48   
Monocytes 3-6   
Eosinophil
s 
0-3   
Basophils 0-1   
                                                                                         Signature of Principal Investigator 
 
   Signature of Lecturer:  
                 
  Signature of HOD     
 
 
 
  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL,  CHENNAI – 600 047 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR  THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 
1.  S.l. No:    2. OP/ IP No  :                           3.Name:                                                              
4.Age:       5.Gender:     6.Date:       
7.Informant:    8.Reliablity:   
                                              DRUG COMPLIANCE 
NAME OF THE DRUG                         :   SIRUPULLADI  ENNAI 
FORM OF THE DRUG                         :    OIL 
ADMINISTRATION                            :     PER ORAL  
DOSE & DURATION                          :     1.6ML – BD for 3DAYS 
NO. OF DRUG PACKETS GIVEN     :    
NO. OF DRUG PACKETS RETURNED :  
DAY DATE OF          
DRUG    INTAKE 
MORNING 
  
EVENING 
  
DAY 1     
DAY 2    
DAY 3    
       
 
     Signature of Lecturer:                                               Signature of Principal Investigator 
             Signature of HOD                                
                                                                                            
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL,  CHENNAI – 600 047 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR  THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN CLINICAL 
TRIAL. 
 
I, ________________________________________Studying as PG Scholar in the department of 
kuzhandhai Maruthuvam  at National Institute of  Siddha, Tambaram Sanatorium is 
doing a clinical study  on  NEERKANA MANTHAM [URI].   In this regard, I am in a need 
to ask you few questions. I will maintain confidentiality of your response  and data 
obtained from you. There will be no risk is involved by taking part in this study. 
 
.           You can choose not to take part. You can choose not to answer a specific 
question. However, taking part in the study may be of benefit to the scientific 
community, as it may help us to understand the problem of  and potential solutions. 
 
             If you agree your child to be a participant in this study, he/she will be 
included in the study primarily by signing the consent form and then you will be given 
the internal medicine SIRUPULLADI  ENNAI-(1.6ml-Twise a day  in morning &evening 
after food for 3days). 
 
             The information I am collecting in this study will remain between you and the 
principal investigator (myself).If you wish to find out more about this study before 
taking part, you can ask me any related  questions  or contact me through my mobile 
number 9962800745. 
 
You can also contact the Member-secretary of Ethics committee, National 
Institute Siddha,Chennai 600047, Tel no : 91-44-22380789,for rights and participation 
in the study 
                          பதசின சித்த நருத்துய ஥ிறுய஦ம் 
     அபனாத்திதாச ஧ண்டிதர் நருத்துயநட஦ பசன்ட஦-47 
           ஧ட்டபநற்஧டிப்பு குமந்டத நருத்துயத்துட஫ 
     
஥ீர்கண நாந்தம் ப஥ாய்க்கா஦ சித்த நருந்தின் (rpWGs;sb எண்பணய் ) ஧ரிகரிப்பு 
தி஫ட஦க் கண்ட஫ிம௃ம் நருத்துய ஆய்யிற்கா஦ தகயல் ஧டியம். 
 
 ஆபாய்ச்சினா஭ர் ப஧னர் ஧ா.அனு஧ா஬ா. 
பதசின சித்த நருத்துய ஥ிறுய஦த்தில் ஧ட்ட பநற்஧டிப்பு ஧னின்று யரும் ஥ான் ஥ீர்கண 
நாந்தம் என்னும் ப஥ானில் நருத்துய ஆபாய்ச்சினில் ஈடு஧ட்டுப஭ன். 
஥ீர்கண நாந்தம் என்னும் சித்த நருத்துயத்தில்  பசால்஬ப்஧டும் ப஥ானா஦து 
இருநல்,மூக்கு ஥ீர் யடிதல்,சுபம்,தட஬ புபட்டல்,உடல் முகம் பசார்யடடதல், முத஬ின 
கு஫ிகுணங்கள் காணப்஧டும் தன்டநம௃டடனது. 
              இந்த ஆபாய்ச்சி சம்நந்தநாக சி஬ பகள்யிகள் பகட்கவும், பதடயனா஦ ஆய்யக 
஧ரிபசாதட஦க்கு தங்க஭து குமந்டதடன உட்஧டுத்தவும் உள்ப஭ன். 
              இது சம்நந்தநா஦ தங்க஭து குமந்டதனின்  அட஦த்து யியபங்களும் பகசினநாக 
டயக்கப்஧டும் எ஦ உறுதி அ஭ிக்கிப஫ன்.இதில் ஧னணப்஧டி முத஬ின எந்த உதயி 
பதாடகம௃ம் யமங்கப்஧ட நாட்டாது. 
              இந்த ஆபாய்ச்சினின் ப஧ாது தங்க஭து குமந்டதனின் உடலுக்கு பயறு ஧ாதிப்பு 
ஏற்஧டும் ஧ட்சத்தில் பதசின சித்த நருத்துயநட஦னில் தக்க சிசிச்டச அ஭ிக்கப்஧டும். 
              இந்த ஆபாய்ச்சிக்கு தங்கள் யிருப்஧த்தின் ப஧ரில்  குமந்டதடன உட்஧டுத்தும் 
஧ட்சத்தில் உள்நருந்தாக  rpWGs;sb எண்பணய் 1.6 நி஬ி 3 ஥ாட்கள் எடுக்க பயண்டும். 
              இந்த ஆபாய்ச்சினில் ப஥ானி஦பக பசர்ந்த ஧ி஫கு உங்களுக்கு யிருப்஧ம் 
இல்ட஬பன஦ில் எப்ப஧ாது பயண்டுநா஦ாலும் தங்க஭து குமந்டதடன யி஬க்கிக் 
பகாள்஭஬ாம். 
              இந்த ஆபாய்ச்சி சம்நந்தநாக நற்஫ யி஧பங்களுக்கும் ப஥ானின் தன்டந ஧ற்஫ிம௃ம் 
அ஫ியதற்கும் முதன்டந ஆபாய்ச்சினா஭பா஦ ஧ா.அனு஧ா஬ா.  (஧ட்ட பநற்஧டிப்஧ா஭ர் குமந்டத 
நருத்துய ஧ிரிவு) டகப஧சி எண் 9962800745 எப்ப஧ாதும் பதாடர்பு பகாள்஭஬ாம். 
               பநலும் இந்த ஆபாய்ச்சிக்கு IEC (஥ிறுய஦ ஥ீதிப஥஫ிகுழு) சான்று ப஧஫ப்஧ட்டுள்஭து. 
              இந்த நருத்து சி஫ப்஧ாக ஥ீர்கண நாந்தம் ப஥ாய்க்காக அங்கீகரிக்கப்஧ட்ட சித்த 
நருத்துய  நூ஬ில் கூ஫ப்஧ட்டுள்஭து. ஏற்க஦பய உ஧பனாகத்தில் உள்஭து  . இதுயடப 
ப஥ானா஭ிக஭ிடம் எந்த யித ஧க்க யிட஭வுகட஭ ஏற்஧டுத்தயில்ட஬. 
               
 
                                         
 
 
 
 
 
 
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 1.  S.I  No:   2. OP/ IP No:                           3.Name:   
 4. Age:       5.Gender:   6.Date:      
7. Informant:   8.Reliablity:   
WITHDRAWAL FORM 
Date of trial commencement   : 
Date of withdrawal from trial  : 
Reason(s) for withdrawal   :  
Long absence at reporting   : Yes/ No 
Irregular treatment    : Yes/ No 
Shift of locality      : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms  : Yes/ No 
 Patient not willing to continue             : Yes/ No 
 
Date:    Signature of Principal Investigator 
 
 
                                           NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL,  CHENNAI – 600 047 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR  THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 
              1.  S.No:                2. OP/ IP No  :                           3.Name:                                                  
          4.Age                                     5.Gender:                 6.Date:       
  7. Informant:               8.Reliablity:   
                                             
                             ADVERSE REACTION 
 
Name       : 
Age      : 
sex                             : 
OPD/ IPD No                                            : 
Date of occurrence                                    : 
Date of withdrawal from trial                   : 
Description of adverse reaction                : 
Clinical condition                                     : 
 
Date:                                                                                   Signature of Principal Investigator 
 
 
 
                                    NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 
 CLINICAL EVALUATION OF SIRUPULLADI  ENNAI (A SIDDHA DRUG) FOR  THE 
TREATMENT OF NEERKANAMANTHAM (URI) IN CHILDREN. 
 
                       DIET FORM 
உணவு ஧த்தின முட஫கள் 
 தூதுபயட஭ பசம், துடயனல் பகாடுக்கவும். 
 சூப் யடககள் பகாடுக்கவும். 
 ஧ா஬ில் நி஭குத் தூள், ஧஦ங்கற்கண்டு க஬ந்து பகாடுக்கவும். 
 து஭சிச் சாற்஫ில் பதன் க஬ந்து பகாடுக்கவும் 
 புடக, தூசி, ஧஦ிகாற்஫ில் ஥டநாடுயடத தயிர்க்கவும். 
 கு஭ிர்ச்சி, இ஦ிப்பு ப஧ாருட்கட஭ தயிர்க்கவும். 
     
 
 
 
 
 
 
 
பதசின சித்த நருத்துய ஥ிறுய஦ம் 
அபனாத்திதாச ஧ண்டிதர் நருத்துயநட஦ பசன்ட஦-47 
஧ட்டபநற்஧டிப்பு குமந்டத நருத்துயத்துட஫ 
 
 
                        rpWGs;sb எண்பணய் ஧ரிகரிப்புத் தி஫ட஦க் கண்ட஫ிம௃ம் 
நருத்துய ஆய்வு  
                                ஒப்புதல் ஧டியம்  
஥ான் இந்த நருத்துய ஆய்டய கு஫ித்த அட஦த்து யி஧பங்கட஭ம௃ம் 
ப஥ானா஭ினின் ப஧ற்ப஫ாருக்கு புரிம௃ம் யடகனில் எடுத்துடபத்பதன் எ஦ 
உறுதி அ஭ிக்கிப஫ன். 
 
பததி:                                               டகபனாப்஧ம்: 
இடம்:                                                ப஧னர்: 
          ப஥ானா஭ினின் ப஧ற்ப஫ார் ஒப்புதல் ஧டியம் 
என்஦ிடம் இந்த நருத்துய ஆய்யின் காபணத்டதம௃ம் ,நருந்தின் 
தன்டந நற்றும் நருத்துய யமிமுட஫ப் ஧ற்஫ிம௃ம் ,இந்த நருத்துயத்டத 
பதாடர்ந்து எ஦து குமந்டதனின் உடல் இனக்கத்டதக் 
கண்காணிக்கவும்,அதட஦த் ஧ாதுகாக்க ஧னன்஧டும் நருத்துய ஆய்வுக்கூடப் 
஧ரிபசாதட஦கள் ஧ற்஫ிம௃ம் திருப்தி அ஭ிக்கும் யடகனில் ஆய்வு 
நருத்துயபால் யி஭க்கிக் கூ஫ப்஧ட்டது. 
஥ான் இந்த நருத்துய ஆய்யின் ப஧ாது எப்ப஧ாது பயண்டுநா஦ாலும் 
என் குமந்டதடன யிடுயித்துக் பகாள்ளும் உரிடநடன பதரிந்திருக்கிப஫ன். 
஥ான் என்னுடடன சுதந்திபநாக பதர்வு பசய்ம௃ம் உரிடநடனக் 
பகாண்டு ஥ீர்கண நாந்தம்  ப஥ாய்க்கா஦ rpWGs;sb எண்பணய் ஧ரிகரிப்புத் 
தி஫ட஦ கண்ட஫ிம௃ம் நருத்துய ஆய்வுக்கு எ஦து குமந்டதடன உட்஧டுத்த 
ஒப்புதல் அ஭ிக்கிப஫ன். 
பததி:                                         ப஧ற்ப஫ார் ப஧னர்: 
 இடம்:                                         டகபனாப்஧ம்:                     
           சாட்சிக்காபர் ப஧னர்: 
                                      உ஫வு முட஫: 
                                     டகபனாப்஧ம்: 
 
 
 
 
 
 
Services offered: Standardization and Characterization of AYUSH formulations 
In-vitro and In-silico Evaluations/ Instrumental analysis/Histopathological Analysis 
Blood & Serum Estimations 
Thesis Writing/ Research Article Preparation and Publication Services 
Noble Research Solutions 
We Trust in Quality and Ethics 
Date: 31.03.2017 
To, 
Dr.Anubala 
National Institute of Siddha 
Tambaram Sanatorium, Chennai - 600 047, Tamil Nadu, India. 
Project Id : NRS/AS/0024/02/2017 
This is to certify that Dr.Anubala from National Institute of Siddha, Chennai has carried 
out the following activity at our facility for the trial drug Sirupuladi Oil (SPO) 
Project Delivery Report 
S.No Study Description Annexure no 
1. Standardization and Physicochemical Evaluation of study 
drug Sirupuladi Oil (SPO) 
I 
2. In-vitro Anti-Inflammatory Evaluation of Sirupuladi Oil 
(SPO) by Protein (Albumin) denaturation Assay 
II 
Note: 
Annexures was attached as a separate enclosure along with this report. 
E-mail: nobleresearchsolutions@gmail.com 
Contact: 9710437419, Admin: 044 - 42691289 
 
 
 
 
 
 
 
 
 
 
 
 


 
